1. Ator MA, Schmidt SJ, Adams JL, Dolle RE, Kruse LI, Frey CL, Barone JM.. (1992) Synthesis, specificity, and antifungal activity of inhibitors of the Candida albicans delta 24-sterol methyltransferase., 35 (1): [PMID:1732516] [10.1021/jm00079a012] |
2. Ogata M, Matsumoto H, Takahashi K, Shimizu S, Kida S, Murabayashi A, Shiro M, Tawara K.. (1987) Synthesis and oral antifungal activity of novel azolylpropanolones and related compounds., 30 (6): [PMID:3585904] [10.1021/jm00389a016] |
3. James MO, Sloan KB.. (1985) Structural features of imidazole derivatives that enhance styrene oxide hydrolase activity in rat hepatic microsomes., 28 (8): [PMID:4020834] [10.1021/jm00146a028] |
4. Firestone RA, Pisano JM, Garrity GM, Fromtling RA, Zimmerman SB.. (1987) Lysosomotropic agents. 7. Broad-spectrum antifungal activity of lysosomotropic detergents., 30 (8): [PMID:3302260] [10.1021/jm00391a043] |
5. Firestone RA, Pisano JM, Garrity GM, Fromtling RA, Zimmerman SB.. (1987) Lysosomotropic agents. 7. Broad-spectrum antifungal activity of lysosomotropic detergents., 30 (8): [PMID:3302260] [10.1021/jm00391a043] |
6. Schwab D, Fischer H, Tabatabaei A, Poli S, Huwyler J.. (2003) Comparison of in vitro P-glycoprotein screening assays: recommendations for their use in drug discovery., 46 (9): [PMID:12699389] [10.1021/jm021012t] |
7. Szajnman SH, Yan W, Bailey BN, Docampo R, Elhalem E, Rodriguez JB.. (2000) Design and synthesis of aryloxyethyl thiocyanate derivatives as potent inhibitors of Trypanosoma cruzi proliferation., 43 (9): [PMID:10794699] [10.1021/jm9905007] |
8. Pour M, Spulák M, Balsánek V, Kunes J, Buchta V, Waisser K.. (2000) 3-Phenyl-5-methyl-2H,5H-furan-2-ones: tuning antifungal activity by varying substituents on the phenyl ring., 10 (16): [PMID:10969993] [10.1016/s0960-894x(00)00376-0] |
9. Njar VC, Nnane IP, Brodie AM.. (2000) Potent inhibition of retinoic acid metabolism enzyme(s) by novel azolyl retinoids., 10 (17): [PMID:10987414] [10.1016/s0960-894x(00)00391-7] |
10. Emmer G, Grassberger MA, Meingassner JG, Schulz G, Schaude M.. (1994) Derivatives of a novel cyclopeptolide. 1. Synthesis, antifungal activity, and structure-activity relationships., 37 (13): [PMID:8027972] [10.1021/jm00039a002] |
11. Mullen GB, DeCory TR, Mitchell JT, Allen SD, Kinsolving CR, Georgiev VS.. (1988) Studies on antifungal agents. 23. Novel substituted 3,5-diphenyl-3-(1H-imidazol-1-ylmethyl)- 2-alkylisoxazolidine derivatives., 31 (10): [PMID:3172137] [10.1021/jm00118a027] |
12. De B, Plattner JJ, Bush EN, Jae HS, Diaz G, Johnson ES, Perun TJ.. (1989) LH-RH antagonists: design and synthesis of a novel series of peptidomimetics., 32 (9): [PMID:2549244] [10.1021/jm00129a003] |
13. Nussbaumer P, Dorfstätter G, Grassberger MA, Leitner I, Meingassner JG, Thirring K, Stütz A.. (1993) Synthesis and structure-activity relationships of phenyl-substituted benzylamine antimycotics: a novel benzylbenzylamine antifungal agent for systemic treatment., 36 (15): [PMID:8340915] [10.1021/jm00067a010] |
14. Ram VJ, Nath M, Shukla P. (1997) 1,3-Dithian-2-ylidene and thiazolidin-2-ylidene derivatives as a novel class of antimycotic agents, 7 (16): [10.1016/S0960-894X(97)00380-6] |
15. Saha AK, Liu L, Simoneaux RL, Kukla MJ, Marichal P, Odds F.. (2000) Novel antifungals based on 4-substituted imidazole: a combinatorial chemistry approach to lead discovery and optimization., 10 (19): [PMID:11012023] [10.1016/s0960-894x(00)00445-5] |
16. Walker KA, Kertesz DJ, Rotstein DM, Swinney DC, Berry PW, So OY, Webb AS, Watson DM, Mak AY, Burton PM.. (1993) Selective inhibition of mammalian lanosterol 14 alpha-demethylase: a possible strategy for cholesterol lowering., 36 (15): [PMID:8340925] [10.1021/jm00067a022] |
17. Jarman M, Barrie SE, Deadman JJ, Houghton J, McCague R, Rowlands MG.. (1990) Hydroxyperfluoroazobenzenes: novel inhibitors of enzymes of androgen biosynthesis., 33 (9): [PMID:2391687] [10.1021/jm00171a019] |
18. Potter GA, Barrie SE, Jarman M, Rowlands MG.. (1995) Novel steroidal inhibitors of human cytochrome P45017 alpha (17 alpha-hydroxylase-C17,20-lyase): potential agents for the treatment of prostatic cancer., 38 (13): [PMID:7608911] [10.1021/jm00013a022] |
19. Pour M, Spulák M, Buchta V, Kubanová P, Voprsalová M, Wsól V, Fáková H, Koudelka P, Pourová H, Schiller R.. (2001) 3-Phenyl-5-acyloxymethyl-2H,5H-furan-2-ones: synthesis and biological activity of a novel group of potential antifungal drugs., 44 (17): [PMID:11495582] [10.1021/jm010155x] |
20. Tafi A, Costi R, Botta M, Di Santo R, Corelli F, Massa S, Ciacci A, Manetti F, Artico M.. (2002) Antifungal agents. 10. New derivatives of 1-[(aryl)[4-aryl-1H-pyrrol-3-yl]methyl]-1H-imidazole, synthesis, anti-candida activity, and quantitative structure-analysis relationship studies., 45 (13): [PMID:12061875] [10.1021/jm011087h] |
21. Keserü GM.. (2003) Prediction of hERG potassium channel affinity by traditional and hologram qSAR methods., 13 (16): [PMID:12873512] [10.1016/s0960-894x(03)00492-x] |
22. Rotstein DM, Kertesz DJ, Walker KA, Swinney DC.. (1992) Stereoisomers of ketoconazole: preparation and biological activity., 35 (15): [PMID:1495014] [10.1021/jm00093a015] |
23. Rotstein DM, Kertesz DJ, Walker KA, Swinney DC.. (1992) Stereoisomers of ketoconazole: preparation and biological activity., 35 (15): [PMID:1495014] [10.1021/jm00093a015] |
24. Cole PA, Robinson CH.. (1990) Mechanism and inhibition of cytochrome P-450 aromatase., 33 (11): [PMID:2231592] [10.1021/jm00173a001] |
25. Ram VJ, Goel A, Shukla P, Kapil A. (1997) Synthesis of thiophenes and thieno[3,2-c]pyran-4-ones as antileishmanial and antifungal agents, 7 (24): [10.1016/S0960-894X(97)10153-6] |
26. Wright SW, Harris RR, Collins RJ, Corbett RL, Green AM, Wadman EA, Batt DG.. (1992) Novel 1-(pyridylphenyl)-1-phenyl-2-imidazolylethanols with topical antiinflammatory activity., 35 (17): [PMID:1507204] [10.1021/jm00095a009] |
27. Rodriguez JB, Zhong L, Docampo R, Wimmer Z, Gros EG.. (1998) Growth inhibitory effect of juvenile hormone analogues on epimastigotes of Trypanosoma cruzi., 8 (22): [PMID:9873713] [10.1016/s0960-894x(98)00590-3] |
28. Ling YZ, Li JS, Liu Y, Kato K, Klus GT, Brodie A.. (1997) 17-Imidazolyl, pyrazolyl, and isoxazolyl androstene derivatives. Novel steroidal inhibitors of human cytochrome C17,20-lyase (P450(17 alpha)., 40 (20): [PMID:9379450] [10.1021/jm970337k] |
29. Tewari N, Tiwari VK, Tripathi RP, Chaturvedi V, Srivastava A, Srivastava R, Shukla PK, Chaturvedi AK, Gaikwad A, Sinha S, Srivastava BS.. (2004) Synthesis of galactopyranosyl amino alcohols as a new class of antitubercular and antifungal agents., 14 (2): [PMID:14698152] [10.1016/j.bmcl.2003.11.020] |
30. Chan FC, Potter GA, Barrie SE, Haynes BP, Rowlands MG, Houghton J, Jarman M.. (1996) 3- and 4-pyridylalkyl adamantanecarboxylates: inhibitors of human cytochrome P450(17 alpha) (17 alpha-hydroxylase/C17,20-lyase). Potential nonsteroidal agents for the treatment of prostatic cancer., 39 (17): [PMID:8765515] [10.1021/jm950749y] |
31. Verras A, Kuntz ID, Ortiz de Montellano PR.. (2004) Computer-assisted design of selective imidazole inhibitors for cytochrome p450 enzymes., 47 (14): [PMID:15214784] [10.1021/jm030608t] |
32. Wu YJ, Davis CD, Dworetzky S, Fitzpatrick WC, Harden D, He H, Knox RJ, Newton AE, Philip T, Polson C, Sivarao DV, Sun LQ, Tertyshnikova S, Weaver D, Yeola S, Zoeckler M, Sinz MW.. (2003) Fluorine substitution can block CYP3A4 metabolism-dependent inhibition: identification of (S)-N-[1-(4-fluoro-3- morpholin-4-ylphenyl)ethyl]-3- (4-fluorophenyl)acrylamide as an orally bioavailable KCNQ2 opener devoid of CYP3A4 metabolism-dependent inhibition., 46 (18): [PMID:12930139] [10.1021/jm034111v] |
33. Bartroli J, Turmo E, Algueró M, Boncompte E, Vericat ML, García-Rafanell J, Forn J.. (1995) Synthesis and antifungal activity of new azole derivatives containing an N-acylmorpholine ring., 38 (20): [PMID:7562925] [10.1021/jm00020a005] |
34. Elhalem E, Bailey BN, Docampo R, Ujváry I, Szajnman SH, Rodriguez JB.. (2002) Design, synthesis, and biological evaluation of aryloxyethyl thiocyanate derivatives against Trypanosoma cruzi., 45 (18): [PMID:12190320] [10.1021/jm0201518] |
35. Rowlands MG, Barrie SE, Chan F, Houghton J, Jarman M, McCague R, Potter GA.. (1995) Esters of 3-pyridylacetic acid that combine potent inhibition of 17 alpha-hydroxylase/C17,20-lyase (cytochrome P45017 alpha) with resistance to esterase hydrolysis., 38 (21): [PMID:7473546] [10.1021/jm00021a008] |
36. Artico M, Di Santo R, Costi R, Massa S, Retico A, Artico M, Apuzzo G, Simonetti G, Strippoli V.. (1995) Antifungal agents. 9. 3-Aryl-4-[alpha-(1H-imidazol-1-yl)arylmethyl]pyrroles: a new class of potent anti-Candida agents., 38 (21): [PMID:7473549] [10.1021/jm00021a011] |
37. Hartmann RW, Hector M, Haidar S, Ehmer PB, Reichert W, Jose J.. (2000) Synthesis and evaluation of novel steroidal oxime inhibitors of P450 17 (17 alpha-hydroxylase/C17-20-lyase) and 5 alpha-reductase types 1 and 2., 43 (22): [PMID:11063622] [10.1021/jm001008m] |
38. Li JS, Li Y, Son C, Brodie AM.. (1996) Synthesis and evaluation of pregnane derivatives as inhibitors of human testicular 17 alpha-hydroxylase/C17,20-lyase., 39 (21): [PMID:8863811] [10.1021/jm960245f] |
39. Colmenarejo G, Alvarez-Pedraglio A, Lavandera JL.. (2001) Cheminformatic models to predict binding affinities to human serum albumin., 44 (25): [PMID:11728183] [10.1021/jm010960b] |
40. Hartmann RW, Hector M, Wachall BG, Palusczak A, Palzer M, Huch V, Veith M.. (2000) Synthesis and evaluation of 17-aliphatic heterocycle-substituted steroidal inhibitors of 17alpha-hydroxylase/C17-20-lyase (P450 17)., 43 (23): [PMID:11087568] [10.1021/jm991070n] |
41. Dyer RL, Ellames GJ, Hamill BJ, Manley PW, Pope AM.. (1983) Synthesis of (E)-1-(5-chlorothien-2-yl)-2-(1H-imidazol-1-yl)ethanone 2,6-dichlorophenylhydrazone hydrochloride, a novel, orally active antifungal agent., 26 (3): [PMID:6298430] [10.1021/jm00357a023] |
42. Seidler J, McGovern SL, Doman TN, Shoichet BK.. (2003) Identification and prediction of promiscuous aggregating inhibitors among known drugs., 46 (21): [PMID:14521410] [10.1021/jm030191r] |
43. Pajeva IK, Wiese M.. (2002) Pharmacophore model of drugs involved in P-glycoprotein multidrug resistance: explanation of structural variety (hypothesis)., 45 (26): [PMID:12477351] [10.1021/jm020941h] |
44. Phuong T, Khac-Minh T, Van Ha NT, Ngoc Phuong HT.. (2004) Synthesis and antifungal activities of phenylenedithioureas., 14 (3): [PMID:14741262] [10.1016/j.bmcl.2003.11.044] |
45. Recanatini M, Bisi A, Cavalli A, Belluti F, Gobbi S, Rampa A, Valenti P, Palzer M, Palusczak A, Hartmann RW.. (2001) A new class of nonsteroidal aromatase inhibitors: design and synthesis of chromone and xanthone derivatives and inhibition of the P450 enzymes aromatase and 17 alpha-hydroxylase/C17,20-lyase., 44 (5): [PMID:11262078] [10.1021/jm000955s] |
46. Agarwal N, Raghuwanshi SK, Upadhyay DN, Shukla PK, Ram VJ.. (2000) Suitably functionalised pyrimidines as potential antimycotic agents., 10 (8): [PMID:10782668] [10.1016/s0960-894x(00)00091-3] |
47. Heeres J, Backx LJ, Van Cutsem J.. (1984) Antimycotic azoles. 7. Synthesis and antifungal properties of a series of novel triazol-3-ones., 27 (7): [PMID:6330360] [10.1021/jm00373a015] |
48. Njar VC, Kato K, Nnane IP, Grigoryev DN, Long BJ, Brodie AM.. (1998) Novel 17-azolyl steroids, potent inhibitors of human cytochrome 17 alpha-hydroxylase-C17,20-lyase (P450(17) alpha): potential agents for the treatment of prostate cancer., 41 (6): [PMID:9526564] [10.1021/jm970568r] |
49. Ulmschneider S, Müller-Vieira U, Mitrenga M, Hartmann RW, Oberwinkler-Marchais S, Klein CD, Bureik M, Bernhardt R, Antes I, Lengauer T.. (2005) Synthesis and evaluation of imidazolylmethylenetetrahydronaphthalenes and imidazolylmethyleneindanes: potent inhibitors of aldosterone synthase., 48 (6): [PMID:15771425] [10.1021/jm049600p] |
50. Ulmschneider S, Müller-Vieira U, Klein CD, Antes I, Lengauer T, Hartmann RW.. (2005) Synthesis and evaluation of (pyridylmethylene)tetrahydronaphthalenes/-indanes and structurally modified derivatives: potent and selective inhibitors of aldosterone synthase., 48 (5): [PMID:15743198] [10.1021/jm0492397] |
51. Yee SW, Simons C.. (2004) Synthesis and CYP24 inhibitory activity of 2-substituted-3,4-dihydro-2H-naphthalen-1-one (tetralone) derivatives., 14 (22): [PMID:15482941] [10.1016/j.bmcl.2004.08.040] |
52. Silvestri R, Artico M, La Regina G, Di Pasquali A, De Martino G, D'Auria FD, Nencioni L, Palamara AT.. (2004) Imidazole analogues of fluoxetine, a novel class of anti-Candida agents., 47 (16): [PMID:15267229] [10.1021/jm049856v] |
53. Handratta VD, Vasaitis TS, Njar VC, Gediya LK, Kataria R, Chopra P, Newman D, Farquhar R, Guo Z, Qiu Y, Brodie AM.. (2005) Novel C-17-heteroaryl steroidal CYP17 inhibitors/antiandrogens: synthesis, in vitro biological activity, pharmacokinetics, and antitumor activity in the LAPC4 human prostate cancer xenograft model., 48 (8): [PMID:15828836] [10.1021/jm040202w] |
54. Tobita M, Nishikawa T, Nagashima R.. (2005) A discriminant model constructed by the support vector machine method for HERG potassium channel inhibitors., 15 (11): [PMID:15911273] [10.1016/j.bmcl.2005.03.080] |
55. Voets M, Antes I, Scherer C, Müller-Vieira U, Biemel K, Barassin C, Marchais-Oberwinkler S, Hartmann RW.. (2005) Heteroaryl-substituted naphthalenes and structurally modified derivatives: selective inhibitors of CYP11B2 for the treatment of congestive heart failure and myocardial fibrosis., 48 (21): [PMID:16220979] [10.1021/jm0503704] |
56. Power EC, Ganellin CR, Benton DC.. (2006) Partial structures of ketoconazole as modulators of the large conductance calcium-activated potassium channel (BK(Ca))., 16 (4): [PMID:16359866] [10.1016/j.bmcl.2005.11.001] |
57. Macreadie P, Avery T, Greatrex B, Taylor D, Macreadie I.. (2006) Novel endoperoxides: synthesis and activity against Candida species., 16 (4): [PMID:16297620] [10.1016/j.bmcl.2005.10.101] |
58. Sheng C, Zhang W, Ji H, Zhang M, Song Y, Xu H, Zhu J, Miao Z, Jiang Q, Yao J, Zhou Y, Zhu J, Lü J.. (2006) Structure-based optimization of azole antifungal agents by CoMFA, CoMSIA, and molecular docking., 49 (8): [PMID:16610794] [10.1021/jm051211n] |
59. Voets M, Antes I, Scherer C, Müller-Vieira U, Biemel K, Marchais-Oberwinkler S, Hartmann RW.. (2006) Synthesis and evaluation of heteroaryl-substituted dihydronaphthalenes and indenes: potent and selective inhibitors of aldosterone synthase (CYP11B2) for the treatment of congestive heart failure and myocardial fibrosis., 49 (7): [PMID:16570918] [10.1021/jm060055x] |
60. Owen CP, Dhanani S, Patel CH, Shahid I, Ahmed S.. (2006) Synthesis and biochemical evaluation of a range of potent benzyl imidazole-based compounds as potential inhibitors of the enzyme complex 17alpha-hydroxylase/17,20-lyase (P450(17alpha))., 16 (15): [PMID:16750362] [10.1016/j.bmcl.2006.05.070] |
61. Patel CH, Dhanani S, Owen CP, Ahmed S.. (2006) Synthesis, biochemical evaluation and rationalisation of the inhibitory activity of a range of 4-substituted phenyl alkyl imidazole-based inhibitors of the enzyme complex 17alpha-hydroxylase/17,20-lyase (P450(17alpha))., 16 (18): [PMID:16870430] [10.1016/j.bmcl.2006.06.092] |
62. Ruckenstuhl C, Lang S, Poschenel A, Eidenberger A, Baral PK, Kohút P, Hapala I, Gruber K, Turnowsky F.. (2007) Characterization of squalene epoxidase of Saccharomyces cerevisiae by applying terbinafine-sensitive variants., 51 (1): [PMID:17043127] [10.1128/aac.00988-06] |
63. Krick A, Kehraus S, Gerhäuser C, Klimo K, Nieger M, Maier A, Fiebig HH, Atodiresei I, Raabe G, Fleischhauer J, König GM.. (2007) Potential cancer chemopreventive in vitro activities of monomeric xanthone derivatives from the marine algicolous fungus Monodictys putredinis., 70 (3): [PMID:17291041] [10.1021/np060505o] |
64. Patel JB, Huynh CK, Handratta VD, Gediya LK, Brodie AM, Goloubeva OG, Clement OO, Nanne IP, Soprano DR, Njar VC.. (2004) Novel retinoic acid metabolism blocking agents endowed with multiple biological activities are efficient growth inhibitors of human breast and prostate cancer cells in vitro and a human breast tumor xenograft in nude mice., 47 (27): [PMID:15615521] [10.1021/jm0401457] |
65. Kahraman M, Sinishtaj S, Dolan PM, Kensler TW, Peleg S, Saha U, Chuang SS, Bernstein G, Korczak B, Posner GH.. (2004) Potent, selective and low-calcemic inhibitors of CYP24 hydroxylase: 24-sulfoximine analogues of the hormone 1alpha,25-dihydroxyvitamin D(3)., 47 (27): [PMID:15615534] [10.1021/jm040129+] |
66. Yee SW, Jarno L, Gomaa MS, Elford C, Ooi LL, Coogan MP, McClelland R, Nicholson RI, Evans BA, Brancale A, Simons C.. (2005) Novel tetralone-derived retinoic acid metabolism blocking agents: synthesis and in vitro evaluation with liver microsomal and MCF-7 CYP26A1 cell assays., 48 (23): [PMID:16279770] [10.1021/jm0501681] |
67. Vandeputte P, Tronchin G, Bergès T, Hennequin C, Chabasse D, Bouchara JP.. (2007) Reduced susceptibility to polyenes associated with a missense mutation in the ERG6 gene in a clinical isolate of Candida glabrata with pseudohyphal growth., 51 (3): [PMID:17158937] [10.1128/aac.01510-06] |
68. Sortino M, Delgado P, Juárez S, Quiroga J, Abonía R, Insuasty B, Nogueras M, Rodero L, Garibotto FM, Enriz RD, Zacchino SA.. (2007) Synthesis and antifungal activity of (Z)-5-arylidenerhodanines., 15 (1): [PMID:17049255] [10.1016/j.bmc.2006.09.038] |
69. Avery TD, Macreadie PI, Greatrex BW, Robinson TV, Taylor DK, Macreadie IG.. (2007) Design of endoperoxides with anti-Candida activity., 15 (1): [PMID:17079152] [10.1016/j.bmc.2006.10.021] |
70. Cho SH, Warit S, Wan B, Hwang CH, Pauli GF, Franzblau SG.. (2007) Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis., 51 (4): [PMID:17210775] [10.1128/aac.00055-06] |
71. Aghatabay NM, Neshat A, Karabiyik T, Somer M, Haciu D, Dülger B.. (2007) Synthesis, characterization and antimicrobial activity of Fe(II), Zn(II), Cd(II) and Hg(II) complexes with 2,6-bis(benzimidazol-2-yl) pyridine ligand., 42 (2): [PMID:17189664] [10.1016/j.ejmech.2006.09.023] |
72. Porcal W, Hernández P, Aguirre G, Boiani L, Boiani M, Merlino A, Ferreira A, Maio RD, Castro A, González M, Cerecetto H.. (2007) Second generation of 5-ethenylbenzofuroxan derivatives as inhibitors of Trypanosoma cruzi growth: synthesis, biological evaluation, and structure-activity relationships., 15 (7): [PMID:17287123] [10.1016/j.bmc.2007.01.009] |
73. Katoh T, Akagi T, Noguchi C, Kajimoto T, Node M, Tanaka R, Nishizawa née Iwamoto M, Ohtsu H, Suzuki N, Saito K.. (2007) Synthesis of DL-standishinal and its related compounds for the studies on structure-activity relationship of inhibitory activity against aromatase., 15 (7): [PMID:17287126] [10.1016/j.bmc.2007.01.031] |
74. Shi L, Ge HM, Tan SH, Li HQ, Song YC, Zhu HL, Tan RX.. (2007) Synthesis and antimicrobial activities of Schiff bases derived from 5-chloro-salicylaldehyde., 42 (4): [PMID:17194508] [10.1016/j.ejmech.2006.11.010] |
75. Sun QY, Xu JM, Cao YB, Zhang WN, Wu QY, Zhang DZ, Zhang J, Zhao HQ, Jiang YY.. (2007) Synthesis of novel triazole derivatives as inhibitors of cytochrome P450 14alpha-demethylase (CYP51)., 42 (9): [PMID:17335940] [10.1016/j.ejmech.2007.01.006] |
76. Aghatabay NM, Somer M, Senel M, Dulger B, Gucin F.. (2007) Raman, FT-IR, NMR spectroscopic data and antimicrobial activity of bis[micro2-(benzimidazol-2-yl)-2-ethanethiolato-N,S,S-chloro-palladium(II)] dimer, [(micro2-CH2CH2NHNCC6H4)PdCl]2.C2H5OH complex., 42 (8): [PMID:17350734] [10.1016/j.ejmech.2007.01.011] |
77. Ozbek N, Katircioğlu H, Karacan N, Baykal T.. (2007) Synthesis, characterization and antimicrobial activity of new aliphatic sulfonamide., 15 (15): [PMID:17544281] [10.1016/j.bmc.2007.05.037] |
78. Yao B, Ji H, Cao Y, Zhou Y, Zhu J, Lü J, Li Y, Chen J, Zheng C, Jiang Y, Liang R, Tang H.. (2007) Synthesis and antifungal activities of novel 2-aminotetralin derivatives., 50 (22): [PMID:17900179] [10.1021/jm0701167] |
79. Porcal W, Hernández P, Boiani M, Aguirre G, Boiani L, Chidichimo A, Cazzulo JJ, Campillo NE, Paez JA, Castro A, Krauth-Siegel RL, Davies C, Basombrío MA, González M, Cerecetto H.. (2007) In vivo anti-Chagas vinylthio-, vinylsulfinyl-, and vinylsulfonylbenzofuroxan derivatives., 50 (24): [PMID:17960923] [10.1021/jm070604e] |
80. Park JS, Yu KA, Kang TH, Kim S, Suh YG.. (2007) Discovery of novel indazole-linked triazoles as antifungal agents., 17 (12): [PMID:17433670] [10.1016/j.bmcl.2007.03.074] |
81. Su CR, Ueng YF, Dung NX, Vijaya Bhaskar Reddy M, Wu TS.. (2007) Cytochrome P3A4 inhibitors and other constituents of Fibraurea tinctoria., 70 (12): [PMID:17994701] [10.1021/np0704248] |
82. Labbé C, Faini F, Villagrán C, Coll J, Rycroft DS.. (2007) Bioactive polychlorinated bibenzyls from the liverwort Riccardia polyclada., 70 (12): [PMID:18020419] [10.1021/np070192c] |
83. Pinto-Bazurco Mendieta MA, Negri M, Jagusch C, Hille UE, Müller-Vieira U, Schmidt D, Hansen K, Hartmann RW.. (2008) Synthesis, biological evaluation and molecular modelling studies of novel ACD- and ABD-ring steroidomimetics as inhibitors of CYP17., 18 (1): [PMID:18024111] [10.1016/j.bmcl.2007.10.079] |
84. Jagusch C, Negri M, Hille UE, Hu Q, Bartels M, Jahn-Hoffmann K, Pinto-Bazurco Mendieta MA, Rodenwaldt B, Müller-Vieira U, Schmidt D, Lauterbach T, Recanatini M, Cavalli A, Hartmann RW.. (2008) Synthesis, biological evaluation and molecular modelling studies of methyleneimidazole substituted biaryls as inhibitors of human 17alpha-hydroxylase-17,20-lyase (CYP17). Part I: Heterocyclic modifications of the core structure., 16 (4): [PMID:18061460] [10.1016/j.bmc.2007.10.094] |
85. Frotscher M, Ziegler E, Marchais-Oberwinkler S, Kruchten P, Neugebauer A, Fetzer L, Scherer C, Müller-Vieira U, Messinger J, Thole H, Hartmann RW.. (2008) Design, synthesis, and biological evaluation of (hydroxyphenyl)naphthalene and -quinoline derivatives: potent and selective nonsteroidal inhibitors of 17beta-hydroxysteroid dehydrogenase type 1 (17beta-HSD1) for the treatment of estrogen-dependent diseases., 51 (7): [PMID:18324762] [10.1021/jm701447v] |
86. Liu P, Zhu S, Li P, Xie W, Jin Y, Sun Q, Wu Q, Sun P, Zhang Y, Yang X, Jiang Y, Zhang D.. (2008) Synthesis and SAR studies of biaryloxy-substituted triazoles as antifungal agents., 18 (11): [PMID:18467095] [10.1016/j.bmcl.2008.04.056] |
87. Sortino M, Cechinel Filho V, Corrêa R, Zacchino S.. (2008) N-Phenyl and N-phenylalkyl-maleimides acting against Candida spp.: time-to-kill, stability, interaction with maleamic acids., 16 (1): [PMID:17962024] [10.1016/j.bmc.2007.08.030] |
88. Korosec T, Acimovic J, Seliskar M, Kocjan D, Tacer KF, Rozman D, Urleb U.. (2008) Novel cholesterol biosynthesis inhibitors targeting human lanosterol 14alpha-demethylase (CYP51)., 16 (1): [PMID:17964172] [10.1016/j.bmc.2007.10.001] |
89. Ekins S, Mankowski DC, Hoover DJ, Lawton MP, Treadway JL, Harwood HJ.. (2007) Three-dimensional quantitative structure-activity relationship analysis of human CYP51 inhibitors., 35 (3): [PMID:17194716] [10.1124/dmd.106.013888] |
90. Kouznetsov VV, Vargas Méndez LY, Sortino M, Vásquez Y, Gupta MP, Freile M, Enriz RD, Zacchino SA.. (2008) Antifungal and cytotoxic activities of some N-substituted aniline derivatives bearing a hetaryl fragment., 16 (2): [PMID:17981473] [10.1016/j.bmc.2007.10.034] |
91. Cheng S, Clancy CJ, Nguyen KT, Clapp W, Nguyen MH.. (2007) A Candida albicans petite mutant strain with uncoupled oxidative phosphorylation overexpresses MDR1 and has diminished susceptibility to fluconazole and voriconazole., 51 (5): [PMID:17325226] [10.1128/aac.00182-07] |
92. Zolle IM, Berger ML, Hammerschmidt F, Hahner S, Schirbel A, Peric-Simov B.. (2008) New selective inhibitors of steroid 11beta-hydroxylation in the adrenal cortex. Synthesis and structure-activity relationship of potent etomidate analogues., 51 (7): [PMID:18348518] [10.1021/jm800012w] |
93. Zhang L, Yan K, Zhang Y, Huang R, Bian J, Zheng C, Sun H, Chen Z, Sun N, An R, Min F, Zhao W, Zhuo Y, You J, Song Y, Yu Z, Liu Z, Yang K, Gao H, Dai H, Zhang X, Wang J, Fu C, Pei G, Liu J, Zhang S, Goodfellow M, Jiang Y, Kuai J, Zhou G, Chen X.. (2007) High-throughput synergy screening identifies microbial metabolites as combination agents for the treatment of fungal infections., 104 (11): [PMID:17360571] [10.1073/pnas.0609370104] |
94. Usia T, Iwata H, Hiratsuka A, Watabe T, Kadota S, Tezuka Y.. (2004) Sesquiterpenes and flavonol glycosides from Zingiber aromaticum and their CYP3A4 and CYP2D6 inhibitory activities., 67 (7): [PMID:15270556] [10.1021/np030556a] |
95. Porcal W, Hernández P, Boiani L, Boiani M, Ferreira A, Chidichimo A, Cazzulo JJ, Olea-Azar C, González M, Cerecetto H.. (2008) New trypanocidal hybrid compounds from the association of hydrazone moieties and benzofuroxan heterocycle., 16 (14): [PMID:18547811] [10.1016/j.bmc.2008.05.038] |
96. La Regina G, D'Auria FD, Tafi A, Piscitelli F, Olla S, Caporuscio F, Nencioni L, Cirilli R, La Torre F, De Melo NR, Kelly SL, Lamb DC, Artico M, Botta M, Palamara AT, Silvestri R.. (2008) 1-[(3-Aryloxy-3-aryl)propyl]-1H-imidazoles, new imidazoles with potent activity against Candida albicans and dermatophytes. Synthesis, structure-activity relationship, and molecular modeling studies., 51 (13): [PMID:18529046] [10.1021/jm800009r] |
97. Xiao ZP, Fang RQ, Li HQ, Xue JY, Zheng Y, Zhu HL.. (2008) Enamines as novel antibacterials and their structure-activity relationships., 43 (9): [PMID:18192085] [10.1016/j.ejmech.2007.11.026] |
98. Romeiro NC, Aguirre G, Hernández P, González M, Cerecetto H, Aldana I, Pérez-Silanes S, Monge A, Barreiro EJ, Lima LM.. (2009) Synthesis, trypanocidal activity and docking studies of novel quinoxaline-N-acylhydrazones, designed as cruzain inhibitors candidates., 17 (2): [PMID:19110434] [10.1016/j.bmc.2008.11.065] |
99. Masman MF, Rodríguez AM, Raimondi M, Zacchino SA, Luiten PG, Somlai C, Kortvelyesi T, Penke B, Enriz RD.. (2009) Penetratin and derivatives acting as antifungal agents., 44 (1): [PMID:18430492] [10.1016/j.ejmech.2008.02.019] |
100. Aghatabay NM, Mahmiani Y, Cevik H, Dulger B.. (2009) Synthesis, Raman, FT-IR, NMR spectroscopic data and antimicrobial activity of mixed aza-oxo-thia macrocyclic compounds., 44 (1): [PMID:18417256] [10.1016/j.ejmech.2008.02.038] |
101. Ge HM, Huang B, Tan SH, Shi da H, Song YC, Tan RX.. (2006) Bioactive oligostilbenoids from the stem bark of Hopea exalata., 69 (12): [PMID:17190464] [10.1021/np060242y] |
102. Soriano-Agatón F, Lagoutte D, Poupon E, Roblot F, Fournet A, Gantier JC, Hocquemiller R.. (2005) Extraction, hemisynthesis, and synthesis of canthin-6-one analogues. Evaluation of their antifungal activities., 68 (11): [PMID:16309303] [10.1021/np050250z] |
103. Zacchino S, Rodríguez G, Pezzenati G, Orellana G, Enriz R, Gonzalez Sierra M.. (1997) In vitro evaluation of antifungal properties of 8.O.4'-neolignans., 60 (7): [PMID:9249968] [10.1021/np9605504] |
104. Plaza A, Cinco M, Tubaro A, Pizza C, Piacente S.. (2003) New triterpene glycosides from the stems of Anomospermum grandifolium., 66 (12): [PMID:14695805] [10.1021/np030283j] |
105. Kariba RM, Houghton PJ, Yenesew A.. (2002) Antimicrobial activities of a new schizozygane indoline alkaloid from Schizozygia coffaeoides and the revised structure of isoschizogaline., 65 (4): [PMID:11975502] [10.1021/np010298m] |
106. Kaplancikli ZA, Turan-Zitouni G, Ozdemir A, Revial G.. (2008) New triazole and triazolothiadiazine derivatives as possible antimicrobial agents., 43 (1): [PMID:17499887] [10.1016/j.ejmech.2007.03.019] |
107. Das BC, Madhukumar AV, Anguiano J, Kim S, Sinz M, Zvyaga TA, Power EC, Ganellin CR, Mani S.. (2008) Synthesis of novel ketoconazole derivatives as inhibitors of the human Pregnane X Receptor (PXR; NR1I2; also termed SXR, PAR)., 18 (14): [PMID:18583127] [10.1016/j.bmcl.2008.06.018] |
108. Wire MB, Ballow CH, Borland J, Shelton MJ, Lou Y, Yuen G, Lin J, Lewis EW.. (2007) Fosamprenavir plus ritonavir increases plasma ketoconazole and ritonavir exposure, while amprenavir exposure remains unchanged., 51 (8): [PMID:17517848] [10.1128/aac.00008-07] |
109. Müller FM, Staudigel A, Salvenmoser S, Tredup A, Miltenberger R, Herrmann JV.. (2007) Cross-resistance to medical and agricultural azole drugs in yeasts from the oropharynx of human immunodeficiency virus patients and from environmental Bavarian vine grapes., 51 (8): [PMID:17548494] [10.1128/aac.00459-07] |
110. Escalante A, Gattuso M, Pérez P, Zacchino S.. (2008) Evidence for the mechanism of action of the antifungal phytolaccoside B isolated from Phytolacca tetramera Hauman., 71 (10): [PMID:18816139] [10.1021/np070660i] |
111. Ahlin G, Karlsson J, Pedersen JM, Gustavsson L, Larsson R, Matsson P, Norinder U, Bergström CA, Artursson P.. (2008) Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1., 51 (19): [PMID:18788725] [10.1021/jm8003152] |
112. Konter J, Möllmann U, Lehmann J.. (2008) NO-donors. Part 17: Synthesis and antimicrobial activity of novel ketoconazole-NO-donor hybrid compounds., 16 (17): [PMID:18710813] [10.1016/j.bmc.2008.05.008] |
113. Lucas S, Heim R, Negri M, Antes I, Ries C, Schewe KE, Bisi A, Gobbi S, Hartmann RW.. (2008) Novel aldosterone synthase inhibitors with extended carbocyclic skeleton by a combined ligand-based and structure-based drug design approach., 51 (19): [PMID:18763754] [10.1021/jm800683c] |
114. Meléndez Gómez CM, Kouznetsov VV, Sortino MA, Alvarez SL, Zacchino SA.. (2008) In vitro antifungal activity of polyfunctionalized 2-(hetero)arylquinolines prepared through imino Diels-Alder reactions., 16 (17): [PMID:18752959] [10.1016/j.bmc.2008.07.079] |
115. Aher NG, Pore VS, Mishra NN, Kumar A, Shukla PK, Sharma A, Bhat MK.. (2009) Synthesis and antifungal activity of 1,2,3-triazole containing fluconazole analogues., 19 (3): [PMID:19110424] [10.1016/j.bmcl.2008.12.026] |
116. Leal PC, Mascarello A, Derita M, Zuljan F, Nunes RJ, Zacchino S, Yunes RA.. (2009) Relation between lipophilicity of alkyl gallates and antifungal activity against yeasts and filamentous fungi., 19 (6): [PMID:19232493] [10.1016/j.bmcl.2009.01.061] |
117. Guiraud P, Steiman R, Seigle-Murandi F, Buarque De Gusmao N.. (1999) Antimicrobial and antitumor activities of mycosporulone., 62 (9): [PMID:10514301] [10.1021/np9805084] |
118. Zacchino SA, López SN, Pezzenati GD, Furlán RL, Santecchia CB, Muñoz L, Giannini FA, Rodríguez AM, Enriz RD.. (1999) In vitro evaluation of antifungal properties of phenylpropanoids and related compounds acting against dermatophytes., 62 (10): [PMID:10543891] [10.1021/np9805443] |
119. Usia T, Watabe T, Kadota S, Tezuka Y.. (2005) Potent CYP3A4 inhibitory constituents of Piper cubeba., 68 (1): [PMID:15679319] [10.1021/np0401765] |
120. Kossuga MH, MacMillan JB, Rogers EW, Molinski TF, Nascimento GG, Rocha RM, Berlinck RG.. (2004) (2S,3R)-2-aminododecan-3-ol, a new antifungal agent from the ascidian Clavelina oblonga., 67 (11): [PMID:15568780] [10.1021/np049782q] |
121. Nair MG, Putnam AR, Mishra SK, Mulks MH, Taft WH, Keller JE, Miller JR, Zhu PP, Meinhart JD, Lynn DG.. (1989) Faeriefungin: a new broad-spectrum antibiotic from Streptomyces griseus var. autotrophicus., 52 (4): [PMID:2509636] [10.1021/np50064a022] |
122. Isin EM, Guengerich FP.. (2007) Multiple sequential steps involved in the binding of inhibitors to cytochrome P450 3A4., 282 (9): [PMID:17200113] [10.1074/jbc.m610346200] |
123. Pedersen JM, Matsson P, Bergström CA, Norinder U, Hoogstraate J, Artursson P.. (2008) Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2)., 51 (11): [PMID:18457386] [10.1021/jm7015683] |
124. Jia L, Sun H.. (2008) Support vector machines classification of hERG liabilities based on atom types., 16 (11): [PMID:18448342] [10.1016/j.bmc.2008.04.028] |
125. Wassvik CM, Holmén AG, Draheim R, Artursson P, Bergström CA.. (2008) Molecular characteristics for solid-state limited solubility., 51 (10): [PMID:18396854] [10.1021/jm701587d] |
126. Paoletta S, Steventon GB, Wildeboer D, Ehrman TM, Hylands PJ, Barlow DJ.. (2008) Screening of herbal constituents for aromatase inhibitory activity., 16 (18): [PMID:18778944] [10.1016/j.bmc.2008.08.034] |
127. Amir M, Kumar H, Javed SA.. (2008) Condensed bridgehead nitrogen heterocyclic system: synthesis and pharmacological activities of 1,2,4-triazolo-[3,4-b]-1,3,4-thiadiazole derivatives of ibuprofen and biphenyl-4-yloxy acetic acid., 43 (10): [PMID:18023930] [10.1016/j.ejmech.2007.09.025] |
128. Zhang LN, Cao P, Tan SH, Gu W, Shi L, Zhu HL.. (2008) Synthesis and antimicrobial activities of 7-O-modified genistein derivatives., 43 (7): [PMID:17977623] [10.1016/j.ejmech.2007.09.008] |
129. Martucci WE, Udier-Blagovic M, Atreya C, Babatunde O, Vargo MA, Jorgensen WL, Anderson KS.. (2009) Novel non-active site inhibitor of Cryptosporidium hominis TS-DHFR identified by a virtual screen., 19 (2): [PMID:19059777] [10.1016/j.bmcl.2008.11.054] |
130. Matsumoto M, Hashizume H, Tomishige T, Kawasaki M, Tsubouchi H, Sasaki H, Shimokawa Y, Komatsu M.. (2006) OPC-67683, a nitro-dihydro-imidazooxazole derivative with promising action against tuberculosis in vitro and in mice., 3 (11): [PMID:17132069] [10.1371/journal.pmed.0030466] |
131. Chai X, Zhang J, Yu S, Hu H, Zou Y, Zhao Q, Dan Z, Zhang D, Wu Q.. (2009) Design, synthesis, and biological evaluation of novel 1-(1H-1,2,4-triazole-1-yl)-2-(2,4-difluorophenyl)-3-substituted benzylamino-2-propanols., 19 (6): [PMID:19231179] [10.1016/j.bmcl.2009.01.048] |
132. Serfling A, Wohlrab J, Deising HB.. (2007) Treatment of a clinically relevant plant-pathogenic fungus with an agricultural azole causes cross-resistance to medical azoles and potentiates caspofungin efficacy., 51 (10): [PMID:17620378] [10.1128/aac.00654-07] |
133. Damodiran M, Muralidharan D, Perumal PT.. (2009) Regioselective synthesis and biological evaluation of bis(indolyl)methane derivatized 1,4-disubstituted 1,2,3-bistriazoles as anti-infective agents., 19 (13): [PMID:19447624] [10.1016/j.bmcl.2009.04.131] |
134. Demirci B, Başer KH, Demirci F, Hamann MT.. (2000) New caryophyllene derivatives from Betula litwinowii., 63 (7): [PMID:10924162] [10.1021/np990438g] |
135. Treyvaud Amiguet V, Petit P, Ta CA, Nuñez R, Sánchez-Vindas P, Alvarez LP, Smith ML, Arnason JT, Durst T.. (2006) Phytochemistry and antifungal properties of the newly discovered tree Pleodendron costaricense., 69 (7): [PMID:16872133] [10.1021/np0504863] |
136. Abdel-Kader MS, Bahler BD, Malone S, Werkhoven MC, van Troon F, David, Wisse JH, Bursuker I, Neddermann KM, Mamber SW, Kingston DG.. (1998) DNA-damaging steroidal alkaloids from Eclipta alba from the suriname rainforest1., 61 (10): [PMID:9784152] [10.1021/np970561c] |
137. Sautour M, Miyamoto T, Lacaille-Dubois MA.. (2005) Steroidal saponins from Smilax medica and their antifungal activity., 68 (10): [PMID:16252913] [10.1021/np058060b] |
138. McCarthy PJ, Pitts TP, Gunawardana GP, Kelly-Borges M, Pomponi SA.. (1992) Antifungal activity of meridine, a natural product from the marine sponge Corticium sp., 55 (11): [PMID:1479383] [10.1021/np50089a016] |
139. Chauhan N, Kruppa M, Calderone R.. (2007) The Ssk1p response regulator and Chk1p histidine kinase mutants of Candida albicans are hypersensitive to fluconazole and voriconazole., 51 (10): [PMID:17664325] [10.1128/aac.00929-07] |
140. Perumal P, Mekala S, Chaffin WL.. (2007) Role for cell density in antifungal drug resistance in Candida albicans biofilms., 51 (7): [PMID:17502416] [10.1128/aac.01237-06] |
141. Almyroudis NG, Sutton DA, Fothergill AW, Rinaldi MG, Kusne S.. (2007) In vitro susceptibilities of 217 clinical isolates of zygomycetes to conventional and new antifungal agents., 51 (7): [PMID:17452481] [10.1128/aac.00452-07] |
142. Alvarado-Ramírez E, Torres-Rodríguez JM.. (2007) In vitro susceptibility of Sporothrix schenckii to six antifungal agents determined using three different methods., 51 (7): [PMID:17438048] [10.1128/aac.01176-06] |
143. Padmavathi V, Thriveni P, Sudhakar Reddy G, Deepti D.. (2008) Synthesis and antimicrobial activity of novel sulfone-linked bis heterocycles., 43 (5): [PMID:17692433] [10.1016/j.ejmech.2007.06.011] |
144. Hu Q, Negri M, Jahn-Hoffmann K, Zhuang Y, Olgen S, Bartels M, Müller-Vieira U, Lauterbach T, Hartmann RW.. (2008) Synthesis, biological evaluation, and molecular modeling studies of methylene imidazole substituted biaryls as inhibitors of human 17alpha-hydroxylase-17,20-lyase (CYP17)--part II: Core rigidification and influence of substituents at the methylene bridge., 16 (16): [PMID:18674917] [10.1016/j.bmc.2008.07.011] |
145. Heim R, Lucas S, Grombein CM, Ries C, Schewe KE, Negri M, Müller-Vieira U, Birk B, Hartmann RW.. (2008) Overcoming undesirable CYP1A2 inhibition of pyridylnaphthalene-type aldosterone synthase inhibitors: influence of heteroaryl derivatization on potency and selectivity., 51 (16): [PMID:18672861] [10.1021/jm800377h] |
146. Pinto-Bazurco Mendieta MA, Negri M, Jagusch C, Müller-Vieira U, Lauterbach T, Hartmann RW.. (2008) Synthesis, biological evaluation, and molecular modeling of abiraterone analogues: novel CYP17 inhibitors for the treatment of prostate cancer., 51 (16): [PMID:18672868] [10.1021/jm800355c] |
147. Lucas S, Heim R, Ries C, Schewe KE, Birk B, Hartmann RW.. (2008) In vivo active aldosterone synthase inhibitors with improved selectivity: lead optimization providing a series of pyridine substituted 3,4-dihydro-1H-quinolin-2-one derivatives., 51 (24): [PMID:19049427] [10.1021/jm800888q] |
148. Kraus JM, Verlinde CL, Karimi M, Lepesheva GI, Gelb MH, Buckner FS.. (2009) Rational modification of a candidate cancer drug for use against Chagas disease., 52 (6): [PMID:19239254] [10.1021/jm801313t] |
149. Zachariae U, Giordanetto F, Leach AG.. (2009) Side chain flexibilities in the human ether-a-go-go related gene potassium channel (hERG) together with matched-pair binding studies suggest a new binding mode for channel blockers., 52 (14): [PMID:19534531] [10.1021/jm900002x] |
150. el-Gazzar AB, Hafez HN, Nawwar GA.. (2009) New acyclic nucleosides analogues as potential analgesic, anti-inflammatory, anti-oxidant and anti-microbial derived from pyrimido[4,5-b]quinolines., 44 (4): [PMID:18977557] [10.1016/j.ejmech.2008.09.030] |
151. Fassihi A, Abedi D, Saghaie L, Sabet R, Fazeli H, Bostaki G, Deilami O, Sadinpour H.. (2009) Synthesis, antimicrobial evaluation and QSAR study of some 3-hydroxypyridine-4-one and 3-hydroxypyran-4-one derivatives., 44 (5): [PMID:19056147] [10.1016/j.ejmech.2008.10.022] |
152. Padmavathi V, Sudhakar Reddy G, Padmaja A, Kondaiah P, Ali-Shazia.. (2009) Synthesis, antimicrobial and cytotoxic activities of 1,3,4-oxadiazoles, 1,3,4-thiadiazoles and 1,2,4-triazoles., 44 (5): [PMID:19036476] [10.1016/j.ejmech.2008.10.012] |
153. Panneerselvam P, Rather BA, Ravi Sankar Reddy D, Ramesh Kumar N.. (2009) Synthesis and anti-microbial screening of some Schiff bases of 3-amino-6,8-dibromo-2-phenylquinazolin-4(3H)-ones., 44 (5): [PMID:18603337] [10.1016/j.ejmech.2008.04.010] |
154. Gouveia FL, de Oliveira RM, de Oliveira TB, da Silva IM, do Nascimento SC, de Sena KX, de Albuquerque JF.. (2009) Synthesis, antimicrobial and cytotoxic activities of some 5-arylidene-4-thioxo-thiazolidine-2-ones., 44 (5): [PMID:19027993] [10.1016/j.ejmech.2008.10.006] |
155. Chai X, Zhang J, Hu H, Yu S, Sun Q, Dan Z, Jiang Y, Wu Q.. (2009) Design, synthesis, and biological evaluation of novel triazole derivatives as inhibitors of cytochrome P450 14alpha-demethylase., 44 (5): [PMID:19097674] [10.1016/j.ejmech.2008.11.007] |
156. McNulty J, Nair JJ, Singh M, Crankshaw DJ, Holloway AC, Bastida J.. (2009) Selective cytochrome P450 3A4 inhibitory activity of Amaryllidaceae alkaloids., 19 (12): [PMID:19428250] [10.1016/j.bmcl.2009.04.086] |
157. Fringuelli R, Giacchè N, Milanese L, Cenci E, Macchiarulo A, Vecchiarelli A, Costantino G, Schiaffella F.. (2009) Bulky 1,4-benzoxazine derivatives with antifungal activity., 17 (11): [PMID:19433362] [10.1016/j.bmc.2009.04.051] |
158. Padmavathi V, Nagendra Mohan AV, Thriveni P, Shazia A.. (2009) Synthesis and bioassay of a new class of heterocycles pyrrolyl oxadiazoles/thiadiazoles/triazoles., 44 (5): [PMID:18547683] [10.1016/j.ejmech.2008.04.003] |
159. Mo S, Krunic A, Chlipala G, Orjala J.. (2009) Antimicrobial ambiguine isonitriles from the cyanobacterium Fischerella ambigua., 72 (5): [PMID:19371071] [10.1021/np800751j] |
160. Siddiqui R, Matin A, Warhurst D, Stins M, Khan NA.. (2007) Effect of antimicrobial compounds on Balamuthia mandrillaris encystment and human brain microvascular endothelial cell cytopathogenicity., 51 (12): [PMID:17875991] [10.1128/aac.00373-07] |
161. Liu DF, Li YP, Ou TM, Huang SL, Gu LQ, Huang M, Huang ZS.. (2009) Synthesis and antimultidrug resistance evaluation of icariin and its derivatives., 19 (15): [PMID:19523827] [10.1016/j.bmcl.2009.05.103] |
162. Hille UE, Hu Q, Vock C, Negri M, Bartels M, Müller-Vieira U, Lauterbach T, Hartmann RW.. (2009) Novel CYP17 inhibitors: synthesis, biological evaluation, structure-activity relationships and modelling of methoxy- and hydroxy-substituted methyleneimidazolyl biphenyls., 44 (7): [PMID:19211174] [10.1016/j.ejmech.2009.01.002] |
163. Roy K, Pratim Roy P.. (2009) Comparative chemometric modeling of cytochrome 3A4 inhibitory activity of structurally diverse compounds using stepwise MLR, FA-MLR, PLS, GFA, G/PLS and ANN techniques., 44 (7): [PMID:19128860] [10.1016/j.ejmech.2008.12.004] |
164. Rohini R, Shanker K, Reddy PM, Ho YP, Ravinder V.. (2009) Mono and bis-6-arylbenzimidazo[1,2-c]quinazolines: a new class of antimicrobial agents., 44 (8): [PMID:19371978] [10.1016/j.ejmech.2009.03.022] |
165. Ahmed S, Shahid I, Dhanani S, Owen CP.. (2009) Synthesis and biochemical evaluation of a range of sulfonated derivatives of 4-hydroxybenzyl imidazole as highly potent inhibitors of rat testicular 17alpha-hydroxylase/17,20-lyase (P-450(17alpha))., 19 (16): [PMID:19608417] [10.1016/j.bmcl.2009.06.070] |
166. Marimon R, Serena C, Gené J, Cano J, Guarro J.. (2008) In vitro antifungal susceptibilities of five species of sporothrix., 52 (2): [PMID:18039919] [10.1128/aac.01012-07] |
167. Pontius A, Krick A, Mesry R, Kehraus S, Foegen SE, Müller M, Klimo K, Gerhäuser C, König GM.. (2008) Monodictyochromes A and B, dimeric xanthone derivatives from the marine algicolous fungus Monodictys putredinis., 71 (11): [PMID:18939864] [10.1021/np800392w] |
168. McNulty J, Nair JJ, Singh M, Crankshaw DJ, Holloway AC.. (2009) Structure-activity studies on seco-pancratistatin analogs: potent inhibitors of human cytochrome P450 3A4., 19 (19): [PMID:19713107] [10.1016/j.bmcl.2009.08.032] |
169. Aghatabay NM, Baş A, Kircali A, Sen G, Yazicioğlu MB, Gücin F, Dülger B.. (2009) Synthesis, Raman, FT-IR, NMR spectroscopic characterization, antimicrobial activity, cytotoxicity and DNA binding of new mixed aza-oxo-thia macrocyclic compounds., 44 (11): [PMID:19700225] [10.1016/j.ejmech.2009.07.003] |
170. El-Sayed Ali T.. (2009) Synthesis of some novel pyrazolo[3,4-b]pyridine and pyrazolo[3,4-d]pyrimidine derivatives bearing 5,6-diphenyl-1,2,4-triazine moiety as potential antimicrobial agents., 44 (11): [PMID:19586688] [10.1016/j.ejmech.2009.05.031] |
171. Padmaja A, Payani T, Reddy GD, Padmavathi V.. (2009) Synthesis, antimicrobial and antioxidant activities of substituted pyrazoles, isoxazoles, pyrimidine and thioxopyrimidine derivatives., 44 (11): [PMID:19631423] [10.1016/j.ejmech.2009.06.024] |
172. Min KH, Xia Y, Kim EK, Jin Y, Kaur N, Kim ES, Kim DK, Jung HY, Choi Y, Park MK, Min YK, Lee K, Lee K.. (2009) A novel class of highly potent multidrug resistance reversal agents: disubstituted adamantyl derivatives., 19 (18): [PMID:19679475] [10.1016/j.bmcl.2009.07.127] |
173. Gerpe A, Alvarez G, Benítez D, Boiani L, Quiroga M, Hernández P, Sortino M, Zacchino S, González M, Cerecetto H.. (2009) 5-Nitrofuranes and 5-nitrothiophenes with anti-Trypanosoma cruzi activity and ability to accumulate squalene., 17 (21): [PMID:19811923] [10.1016/j.bmc.2009.09.013] |
174. Renard D, Perruchon J, Giera M, Müller J, Bracher F.. (2009) Side chain azasteroids and thiasteroids as sterol methyltransferase inhibitors in ergosterol biosynthesis., 17 (23): [PMID:19833521] [10.1016/j.bmc.2009.09.037] |
175. Garibotto FM, Garro AD, Masman MF, Rodríguez AM, Luiten PG, Raimondi M, Zacchino SA, Somlai C, Penke B, Enriz RD.. (2010) New small-size peptides possessing antifungal activity., 18 (1): [PMID:19959366] [10.1016/j.bmc.2009.11.009] |
176. Omar K, Geronikaki A, Zoumpoulakis P, Camoutsis C, Soković M, Cirić A, Glamoclija J.. (2010) Novel 4-thiazolidinone derivatives as potential antifungal and antibacterial drugs., 18 (1): [PMID:19914077] [10.1016/j.bmc.2009.10.041] |
177. Majetich G, Shimkus JM.. (2010) The taiwaniaquinoids: a review., 73 (2): [PMID:20102168] [10.1021/np9004695] |
178. Vieira FT, de Lima GM, Maia JR, Speziali NL, Ardisson JD, Rodrigues L, Correa A, Romero OB.. (2010) Synthesis, characterization and biocidal activity of new organotin complexes of 2-(3-oxocyclohex-1-enyl)benzoic acid., 45 (3): [PMID:19959261] [10.1016/j.ejmech.2009.11.026] |
179. Rohini R, Muralidhar Reddy P, Shanker K, Hu A, Ravinder V.. (2010) Antimicrobial study of newly synthesized 6-substituted indolo[1,2-c]quinazolines., 45 (3): [PMID:20005020] [10.1016/j.ejmech.2009.11.038] |
180. McNulty J, Nair JJ, Singh M, Crankshaw DJ, Holloway AC.. (2010) Potent and selective inhibition of human cytochrome P450 3A4 by seco-pancratistatin structural analogs., 20 (7): [PMID:20189386] [10.1016/j.bmcl.2010.01.157] |
181. Mathew BP, Kumar A, Sharma S, Shukla PK, Nath M.. (2010) An eco-friendly synthesis and antimicrobial activities of dihydro-2H-benzo- and naphtho-1,3-oxazine derivatives., 45 (4): [PMID:20116901] [10.1016/j.ejmech.2009.12.058] |
182. Muftuoglu Y, Mustata G.. (2010) Pharmacophore modeling strategies for the development of novel nonsteroidal inhibitors of human aromatase (CYP19)., 20 (10): [PMID:20413308] [10.1016/j.bmcl.2010.03.113] |
183. Wang X, Sena Filho JG, Hoover AR, King JB, Ellis TK, Powell DR, Cichewicz RH.. (2010) Chemical epigenetics alters the secondary metabolite composition of guttate excreted by an atlantic-forest-soil-derived Penicillium citreonigrum., 73 (5): [PMID:20450206] [10.1021/np100142h] |
184. Kraus JM, Tatipaka HB, McGuffin SA, Chennamaneni NK, Karimi M, Arif J, Verlinde CL, Buckner FS, Gelb MH.. (2010) Second generation analogues of the cancer drug clinical candidate tipifarnib for anti-Chagas disease drug discovery., 53 (10): [PMID:20429511] [10.1021/jm9013136] |
185. Ozdemir A, Turan-Zitouni G, Asim Kaplancikli Z, Işcan G, Khan S, Demirci F.. (2010) Synthesis and the selective antifungal activity of 5,6,7,8-tetrahydroimidazo[1,2-a]pyridine derivatives., 45 (5): [PMID:20106559] [10.1016/j.ejmech.2009.12.023] |
186. Gobbi S, Zimmer C, Belluti F, Rampa A, Hartmann RW, Recanatini M, Bisi A.. (2010) Novel highly potent and selective nonsteroidal aromatase inhibitors: synthesis, biological evaluation and structure-activity relationships investigation., 53 (14): [PMID:20568782] [10.1021/jm100319h] |
187. Costa EV, Pinheiro ML, Barison A, Campos FR, Salvador MJ, Maia BH, Cabral EC, Eberlin MN.. (2010) Alkaloids from the bark of Guatteria hispida and their evaluation as antioxidant and antimicrobial agents., 73 (6): [PMID:20476748] [10.1021/np100013r] |
188. Gerpe A, Boiani L, Hernández P, Sortino M, Zacchino S, González M, Cerecetto H.. (2010) Naftifine-analogues as anti-Trypanosoma cruzi agents., 45 (6): [PMID:20163894] [10.1016/j.ejmech.2010.01.052] |
189. Zheng QZ, Cheng K, Zhang XM, Liu K, Jiao QC, Zhu HL.. (2010) Synthesis of some N-alkyl substituted urea derivatives as antibacterial and antifungal agents., 45 (7): [PMID:20381216] [10.1016/j.ejmech.2010.03.027] |
190. Padmavathi V, Mahesh K, Dinneswara Reddy G, Padmaja A.. (2010) Synthesis and bioassay of pyrrolyl oxazolines and thiazolines., 45 (7): [PMID:20444528] [10.1016/j.ejmech.2010.04.010] |
191. Aboraia AS, Yee SW, Gomaa MS, Shah N, Robotham AC, Makowski B, Prosser D, Brancale A, Jones G, Simons C.. (2010) Synthesis and CYP24A1 inhibitory activity of N-(2-(1H-imidazol-1-yl)-2-phenylethyl)arylamides., 18 (14): [PMID:20594862] [10.1016/j.bmc.2010.06.011] |
192. Hu Q, Yin L, Jagusch C, Hille UE, Hartmann RW.. (2010) Isopropylidene substitution increases activity and selectivity of biphenylmethylene 4-pyridine type CYP17 inhibitors., 53 (13): [PMID:20550118] [10.1021/jm100400a] |
193. Olivella MS, Rodríguez AM, Zacchino SA, Somlai C, Penke B, Farkas V, Perczel A, Enriz RD.. (2010) New antifungal peptides. Synthesis, bioassays and initial structure prediction by CD spectroscopy., 20 (16): [PMID:20620056] [10.1016/j.bmcl.2010.06.105] |
194. Ozkay Y, Tunali Y, Karaca H, Işikdağ I.. (2010) Antimicrobial activity and a SAR study of some novel benzimidazole derivatives bearing hydrazone moiety., 45 (8): [PMID:20451306] [10.1016/j.ejmech.2010.04.012] |
195. Xu Y, Pang G, Zhao D, Gao C, Zhou L, Sun S, Wang B.. (2010) In vitro activity of thimerosal against ocular pathogenic fungi., 54 (1): [PMID:19841144] [10.1128/aac.00714-09] |
196. Prado-Prado FJ, García-Mera X, González-Díaz H.. (2010) Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species., 18 (6): [PMID:20185316] [10.1016/j.bmc.2010.01.068] |
197. Hu Q, Jagusch C, Hille UE, Haupenthal J, Hartmann RW.. (2010) Replacement of imidazolyl by pyridyl in biphenylmethylenes results in selective CYP17 and dual CYP17/CYP11B1 inhibitors for the treatment of prostate cancer., 53 (15): [PMID:20684610] [10.1021/jm100317b] |
198. MacDonald ML, Lamerdin J, Owens S, Keon BH, Bilter GK, Shang Z, Huang Z, Yu H, Dias J, Minami T, Michnick SW, Westwick JK.. (2006) Identifying off-target effects and hidden phenotypes of drugs in human cells., 2 (6): [PMID:16680159] [10.1038/nchembio790] |
199. Owen CP, Shahid I, Lee WY, Ahmed S.. (2010) Synthesis and biochemical evaluation of a range of (4-substituted phenyl)sulfonate derivatives of 4-hydroxybenzyl imidazole-based compounds as potent inhibitors of 17alpha-hydroxylase/17,20-lyase (P45017alpha) derived from rat testicular microsomes., 20 (17): [PMID:20675132] [10.1016/j.bmcl.2010.02.100] |
200. Aytemir MD, Ozçelik B.. (2010) A study of cytotoxicity of novel chlorokojic acid derivatives with their antimicrobial and antiviral activities., 45 (9): [PMID:20591538] [10.1016/j.ejmech.2010.05.069] |
201. Liesen AP, de Aquino TM, Carvalho CS, Lima VT, de Araújo JM, de Lima JG, de Faria AR, de Melo EJ, Alves AJ, Alves EW, Alves AQ, Góes AJ.. (2010) Synthesis and evaluation of anti-Toxoplasma gondii and antimicrobial activities of thiosemicarbazides, 4-thiazolidinones and 1,3,4-thiadiazoles., 45 (9): [PMID:20541294] [10.1016/j.ejmech.2010.05.017] |
202. Padmavathi V, Reddy SN, Reddy GD, Padmaja A.. (2010) Synthesis and bioassay of aminosulfonyl-1,3,4-oxadiazoles and their interconversion to 1,3,4-thiadiazoles., 45 (9): [PMID:20630628] [10.1016/j.ejmech.2010.06.022] |
203. Yu S, Chai X, Hu H, Yan Y, Guan Z, Zou Y, Sun Q, Wu Q.. (2010) Synthesis and antifungal evaluation of novel triazole derivatives as inhibitors of cytochrome P450 14alpha-demethylase., 45 (10): [PMID:20675019] [10.1016/j.ejmech.2010.07.002] |
204. Aboraia AS, Makowski B, Bahja A, Prosser D, Brancale A, Jones G, Simons C.. (2010) Synthesis and CYP24A1 inhibitory activity of (E)-2-(2-substituted benzylidene)- and 2-(2-substituted benzyl)-6-methoxy-tetralones., 45 (10): [PMID:20655626] [10.1016/j.ejmech.2010.07.001] |
205. Gu W, Wang S.. (2010) Synthesis and antimicrobial activities of novel 1H-dibenzo[a,c]carbazoles from dehydroabietic acid., 45 (10): [PMID:20702006] [10.1016/j.ejmech.2010.07.038] |
206. Diamandis P, Wildenhain J, Clarke ID, Sacher AG, Graham J, Bellows DS, Ling EK, Ward RJ, Jamieson LG, Tyers M, Dirks PB.. (2007) Chemical genetics reveals a complex functional ground state of neural stem cells., 3 (5): [PMID:17417631] [10.1038/nchembio873] |
207. Cuenca-Estrella M, Gomez-Lopez A, Gutierrez MO, Buitrago MJ, Rodriguez-Tudela JL.. (2008) Reliability of the WIDERYST susceptibility testing system for detection of in vitro antifungal resistance in yeasts., 52 (3): [PMID:18195057] [10.1128/aac.01016-07] |
208. Azor M, Gené J, Cano J, Sutton DA, Fothergill AW, Rinaldi MG, Guarro J.. (2008) In vitro antifungal susceptibility and molecular characterization of clinical isolates of Fusarium verticillioides (F. moniliforme) and Fusarium thapsinum., 52 (6): [PMID:18391027] [10.1128/aac.00176-08] |
209. Yuan J, Johnson RL, Huang R, Wichterman J, Jiang H, Hayton K, Fidock DA, Wellems TE, Inglese J, Austin CP, Su XZ.. (2009) Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum., 5 (10): [PMID:19734910] [10.1038/nchembio.215] |
210. Li XC, Jacob MR, Khan SI, Ashfaq MK, Babu KS, Agarwal AK, Elsohly HN, Manly SP, Clark AM.. (2008) Potent in vitro antifungal activities of naturally occurring acetylenic acids., 52 (7): [PMID:18458131] [10.1128/aac.01297-07] |
211. Parker JE, Merkamm M, Manning NJ, Pompon D, Kelly SL, Kelly DE.. (2008) Differential azole antifungal efficacies contrasted using a Saccharomyces cerevisiae strain humanized for sterol 14 alpha-demethylase at the homologous locus., 52 (10): [PMID:18694951] [10.1128/aac.00517-08] |
212. Vandeputte P, Tronchin G, Larcher G, Ernoult E, Bergès T, Chabasse D, Bouchara JP.. (2008) A nonsense mutation in the ERG6 gene leads to reduced susceptibility to polyenes in a clinical isolate of Candida glabrata., 52 (10): [PMID:18694952] [10.1128/aac.00423-08] |
213. Puri N, Prakash O, Manoharlal R, Sharma M, Ghosh I, Prasad R.. (2010) Analysis of physico-chemical properties of substrates of ABC and MFS multidrug transporters of pathogenic Candida albicans., 45 (11): [PMID:20739103] [10.1016/j.ejmech.2010.07.050] |
214. Mahle F, Guimarães Tda R, Meira AV, Corrêa R, Bella Cruz RC, Bella Cruz A, Nunes RJ, Cechinel-Filho V, de Campos-Buzzi F.. (2010) Synthesis and biological evaluation of N-antipyrine-4-substituted amino-3-chloromaleimide derivatives., 45 (11): [PMID:20708825] [10.1016/j.ejmech.2010.07.040] |
215. Castanys-Muñoz E, Pérez-Victoria JM, Gamarro F, Castanys S.. (2008) Characterization of an ABCG-like transporter from the protozoan parasite Leishmania with a role in drug resistance and transbilayer lipid movement., 52 (10): [PMID:18644961] [10.1128/aac.00587-08] |
216. PubChem BioAssay data set, |
217. PubChem BioAssay data set, |
218. PubChem BioAssay data set, |
219. PubChem BioAssay data set, |
220. PubChem BioAssay data set, |
221. PubChem BioAssay data set, |
222. PubChem BioAssay data set, |
223. PubChem BioAssay data set, |
224. PubChem BioAssay data set, |
225. Pelletier DJ, Gehlhaar D, Tilloy-Ellul A, Johnson TO, Greene N.. (2007) Evaluation of a published in silico model and construction of a novel Bayesian model for predicting phospholipidosis inducing potential., 47 (1): [PMID:17428028] [10.1021/ci6004542] |
226. Cerep in vitro phospholipidosis assay data, |
227. Sun L, Sun S, Cheng A, Wu X, Zhang Y, Lou H.. (2009) In vitro activities of retigeric acid B alone and in combination with azole antifungal agents against Candida albicans., 53 (4): [PMID:19171796] [10.1128/aac.00940-08] |
228. Kuarm BS, Reddy YT, Madhav JV, Crooks PA, Rajitha B.. (2011) 3-[Benzimidazo- and 3-[benzothiadiazoleimidazo-(1,2-c)quinazolin-5-yl]-2H-chromene-2-ones as potent antimicrobial agents., 21 (1): [PMID:21134751] [10.1016/j.bmcl.2010.10.082] |
229. Zimmer C, Hafner M, Zender M, Ammann D, Hartmann RW, Vock CA.. (2011) N-(Pyridin-3-yl)benzamides as selective inhibitors of human aldosterone synthase (CYP11B2)., 21 (1): [PMID:21129965] [10.1016/j.bmcl.2010.11.040] |
230. Marchais-Oberwinkler S, Wetzel M, Ziegler E, Kruchten P, Werth R, Henn C, Hartmann RW, Frotscher M.. (2011) New drug-like hydroxyphenylnaphthol steroidomimetics as potent and selective 17β-hydroxysteroid dehydrogenase type 1 inhibitors for the treatment of estrogen-dependent diseases., 54 (2): [PMID:21189020] [10.1021/jm1009082] |
231. Martel CM, Parker JE, Bader O, Weig M, Gross U, Warrilow AG, Kelly DE, Kelly SL.. (2010) A clinical isolate of Candida albicans with mutations in ERG11 (encoding sterol 14alpha-demethylase) and ERG5 (encoding C22 desaturase) is cross resistant to azoles and amphotericin B., 54 (9): [PMID:20547793] [10.1128/aac.00303-10] |
232. Hille UE, Zimmer C, Vock CA, Hartmann RW.. (2011) First Selective CYP11B1 Inhibitors for the Treatment of Cortisol-Dependent Diseases., 2 (1): [PMID:24900247] [10.1021/ml100071j] |
233. Garibotto FM, Garro AD, Rodríguez AM, Raimondi M, Zacchino SA, Perczel A, Somlai C, Penke B, Enriz RD.. (2011) Penetratin analogues acting as antifungal agents., 46 (1): [PMID:21093119] [10.1016/j.ejmech.2010.10.025] |
234. Lamping E, Ranchod A, Nakamura K, Tyndall JD, Niimi K, Holmes AR, Niimi M, Cannon RD.. (2009) Abc1p is a multidrug efflux transporter that tips the balance in favor of innate azole resistance in Candida krusei., 53 (2): [PMID:19015352] [10.1128/aac.01095-08] |
235. Antonopoulou S, Aoun M, Alexopoulos EC, Baka S, Logothetis E, Kalambokas T, Zannos A, Papadias K, Grigoriou O, Kouskouni E, Velegraki A.. (2009) Fenticonazole activity measured by the methods of the European Committee on Antimicrobial Susceptibility Testing and CLSI against 260 Candida vulvovaginitis isolates from two European regions and annotations on the prevalent genotypes., 53 (5): [PMID:19223627] [10.1128/aac.01413-08] |
236. Tsao S, Rahkhoodaee F, Raymond M.. (2009) Relative contributions of the Candida albicans ABC transporters Cdr1p and Cdr2p to clinical azole resistance., 53 (4): [PMID:19223631] [10.1128/aac.00926-08] |
237. Fraga AG, da Silva LL, Fraga CA, Barreiro EJ.. (2011) CYP1A2-mediated biotransformation of cardioactive 2-thienylidene-3,4-methylenedioxybenzoylhydrazine (LASSBio-294) by rat liver microsomes and human recombinant CYP enzymes., 46 (1): [PMID:21144625] [10.1016/j.ejmech.2010.11.024] |
238. Vandeputte P, Tronchin G, Rocher F, Renier G, Bergès T, Chabasse D, Bouchara JP.. (2009) Hypersusceptibility to azole antifungals in a clinical isolate of Candida glabrata with reduced aerobic growth., 53 (7): [PMID:19380598] [10.1128/aac.01384-08] |
239. Sharma M, Manoharlal R, Shukla S, Puri N, Prasad T, Ambudkar SV, Prasad R.. (2009) Curcumin modulates efflux mediated by yeast ABC multidrug transporters and is synergistic with antifungals., 53 (8): [PMID:19470507] [10.1128/aac.01497-08] |
240. Tezuka Y, Morikawa K, Li F, Auw L, Awale S, Nobukawa T, Kadota S.. (2011) Cytochrome P450 3A4 inhibitory constituents of the wood of Taxus yunnanensis., 74 (1): [PMID:21138310] [10.1021/np100665j] |
241. Tianpanich K, Prachya S, Wiyakrutta S, Mahidol C, Ruchirawat S, Kittakoop P.. (2011) Radical scavenging and antioxidant activities of isocoumarins and a phthalide from the endophytic fungus Colletotrichum sp., 74 (1): [PMID:21174408] [10.1021/np1003752] |
242. Seneviratne CJ, Jin LJ, Samaranayake YH, Samaranayake LP.. (2008) Cell density and cell aging as factors modulating antifungal resistance of Candida albicans biofilms., 52 (9): [PMID:18625775] [10.1128/aac.00541-08] |
243. Warrilow AG, Jackson CJ, Parker JE, Marczylo TH, Kelly DE, Lamb DC, Kelly SL.. (2009) Identification, characterization, and azole-binding properties of Mycobacterium smegmatis CYP164A2, a homolog of ML2088, the sole cytochrome P450 gene of Mycobacterium leprae., 53 (3): [PMID:19075057] [10.1128/aac.01237-08] |
244. van de Sande WW, Fahal AH, Bakker-Woudenberg IA, van Belkum A.. (2010) Madurella mycetomatis is not susceptible to the echinocandin class of antifungal agents., 54 (6): [PMID:20350944] [10.1128/aac.01546-09] |
245. Sinha N, Sen S.. (2011) Predicting hERG activities of compounds from their 3D structures: development and evaluation of a global descriptors based QSAR model., 46 (2): [PMID:21185626] [10.1016/j.ejmech.2010.11.042] |
246. Xiao ZP, He XB, Peng ZY, Xiong TJ, Peng J, Chen LH, Zhu HL.. (2011) Synthesis, structure, molecular docking, and structure-activity relationship analysis of enamines: 3-aryl-4-alkylaminofuran-2(5H)-ones as potential antibacterials., 19 (5): [PMID:21330140] [10.1016/j.bmc.2011.01.051] |
247. Stefanachi A, Favia AD, Nicolotti O, Leonetti F, Pisani L, Catto M, Zimmer C, Hartmann RW, Carotti A.. (2011) Design, synthesis, and biological evaluation of imidazolyl derivatives of 4,7-disubstituted coumarins as aromatase inhibitors selective over 17-α-hydroxylase/C17-20 lyase., 54 (6): [PMID:21341743] [10.1021/jm101120u] |
248. Martel CM, Parker JE, Bader O, Weig M, Gross U, Warrilow AG, Rolley N, Kelly DE, Kelly SL.. (2010) Identification and characterization of four azole-resistant erg3 mutants of Candida albicans., 54 (11): [PMID:20733039] [10.1128/aac.00348-10] |
249. Manzano JI, Carvalho L, Pérez-Victoria JM, Castanys S, Gamarro F.. (2011) Increased glycolytic ATP synthesis is associated with tafenoquine resistance in Leishmania major., 55 (3): [PMID:21199921] [10.1128/aac.01545-10] |
250. Lowe R, Glen RC, Mitchell JB.. (2010) Predicting phospholipidosis using machine learning., 7 (5): [PMID:20799726] [10.1021/mp100103e] |
251. Greene N, Fisk L, Naven RT, Note RR, Patel ML, Pelletier DJ.. (2010) Developing structure-activity relationships for the prediction of hepatotoxicity., 23 (7): [PMID:20553011] [10.1021/tx1000865] |
252. Ekins S, Williams AJ, Xu JJ.. (2010) A predictive ligand-based Bayesian model for human drug-induced liver injury., 38 (12): [PMID:20843939] [10.1124/dmd.110.035113] |
253. Fourches D, Barnes JC, Day NC, Bradley P, Reed JZ, Tropsha A.. (2010) Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species., 23 (1): [PMID:20014752] [10.1021/tx900326k] |
254. Matthews EJ, Kruhlak NL, Weaver JL, Benz RD, Contrera JF.. (2004) Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling., 1 (4): [PMID:16472241] [10.2174/1570163043334794] |
255. Kruhlak NL, Choi SS, Contrera JF, Weaver JL, Willard JM, Hastings KL, Sancilio LF.. (2008) Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models., 18 (2): [PMID:20020916] [10.1080/15376510701857262] |
256. Unpublished dataset, |
257. PubChem BioAssay data set, |
258. (2008) Casarett and Doull's Toxicology The Basic Science of Poisons, 7th edition, |
259. (2008) Casarett and Doull's Toxicology The Basic Science of Poisons, 7th edition, |
260. Padmavathi V, Dinneswara Reddy G, Nagi Reddy S, Mahesh K.. (2011) Synthesis and biological activity of 2-(bis((1,3,4-oxadiazolyl/1,3,4-thiadiazolyl)methylthio)methylene)malononitriles., 46 (4): [PMID:21342736] [10.1016/j.ejmech.2011.01.063] |
261. Lucas S, Negri M, Heim R, Zimmer C, Hartmann RW.. (2011) Fine-tuning the selectivity of aldosterone synthase inhibitors: structure-activity and structure-selectivity insights from studies of heteroaryl substituted 1,2,5,6-tetrahydropyrrolo[3,2,1-ij]quinolin-4-one derivatives., 54 (7): [PMID:21384875] [10.1021/jm101470k] |
262. Abdel-Wahab BF, Awad GE, Badria FA.. (2011) Synthesis, antimicrobial, antioxidant, anti-hemolytic and cytotoxic evaluation of new imidazole-based heterocycles., 46 (5): [PMID:21353349] [10.1016/j.ejmech.2011.01.062] |
263. Sortino M, Garibotto F, Cechinel Filho V, Gupta M, Enriz R, Zacchino S.. (2011) Antifungal, cytotoxic and SAR studies of a series of N-alkyl, N-aryl and N-alkylphenyl-1,4-pyrrolediones and related compounds., 19 (9): [PMID:21481593] [10.1016/j.bmc.2011.03.038] |
264. Liaras K, Geronikaki A, Glamočlija J, Cirić A, Soković M.. (2011) Thiazole-based chalcones as potent antimicrobial agents. Synthesis and biological evaluation., 19 (10): [PMID:21524583] [10.1016/j.bmc.2011.04.007] |
265. Li HQ, Xue JY, Shi L, Gui SY, Zhu HL.. (2008) Synthesis, crystal structure and antimicrobial activity of deoxybenzoin derivatives from genistein., 43 (3): [PMID:17624635] [10.1016/j.ejmech.2007.05.013] |
266. Praveen C, Ayyanar A, Perumal PT.. (2011) Practical synthesis, anticonvulsant, and antimicrobial activity of N-allyl and N-propargyl di(indolyl)indolin-2-ones., 21 (13): [PMID:21621411] [10.1016/j.bmcl.2011.04.117] |
267. Xiao ZP, Ouyang H, Wang XD, Lv PC, Huang ZJ, Yu SR, Yi TF, Yang YL, Zhu HL.. (2011) 4-alkoxy-3-arylfuran-2(5H)-ones as inhibitors of tyrosyl-tRNA synthetase: synthesis, molecular docking and antibacterial evaluation., 19 (13): [PMID:21669535] [10.1016/j.bmc.2011.05.042] |
268. Xu Z, Zhang Y, Fu H, Zhong H, Hong K, Zhu W.. (2011) Antifungal quinazolinones from marine-derived Bacillus cereus and their preparation., 21 (13): [PMID:21612927] [10.1016/j.bmcl.2011.05.002] |
269. Xu J, Cao Y, Zhang J, Yu S, Zou Y, Chai X, Wu Q, Zhang D, Jiang Y, Sun Q.. (2011) Design, synthesis and antifungal activities of novel 1,2,4-triazole derivatives., 46 (7): [PMID:21420761] [10.1016/j.ejmech.2011.02.042] |
270. Jiang X, Liu W, Zhang W, Jiang F, Gao Z, Zhuang H, Fu L.. (2011) Synthesis and antimicrobial evaluation of new benzofuran derivatives., 46 (8): [PMID:21570749] [10.1016/j.ejmech.2011.04.053] |
271. Li C, La MP, Li L, Li XB, Tang H, Liu BS, Krohn K, Sun P, Yi YH, Zhang W.. (2011) Bioactive 11,20-epoxy-3,5(16)-diene briarane diterpenoids from the South China Sea gorgonian Dichotella gemmacea., 74 (7): [PMID:21721519] [10.1021/np200330c] |
272. Zhang W, Liu W, Jiang X, Jiang F, Zhuang H, Fu L.. (2011) Design, synthesis and antimicrobial activity of chiral 2-(substituted-hydroxyl)-3-(benzo[d]oxazol-5-yl)propanoic acid derivatives., 46 (9): [PMID:21641699] [10.1016/j.ejmech.2011.05.028] |
273. Fu P, Wang S, Hong K, Li X, Liu P, Wang Y, Zhu W.. (2011) Cytotoxic bipyridines from the marine-derived actinomycete Actinoalloteichus cyanogriseus WH1-2216-6., 74 (8): [PMID:21770434] [10.1021/np200258h] |
274. Xiao ZP, Ma TW, Liao ML, Feng YT, Peng XC, Li JL, Li ZP, Wu Y, Luo Q, Deng Y, Liang X, Zhu HL.. (2011) Tyrosyl-tRNA synthetase inhibitors as antibacterial agents: synthesis, molecular docking and structure-activity relationship analysis of 3-aryl-4-arylaminofuran-2(5H)-ones., 46 (10): [PMID:21856050] [10.1016/j.ejmech.2011.07.047] |
275. Patel RV, Kumari P, Rajani DP, Chikhalia KH.. (2011) Synthesis and studies of novel 2-(4-cyano-3-trifluoromethylphenyl amino)-4-(quinoline-4-yloxy)-6-(piperazinyl/piperidinyl)-s-triazines as potential antimicrobial, antimycobacterial and anticancer agents., 46 (9): [PMID:21794959] [10.1016/j.ejmech.2011.07.006] |
276. Altıntop MD, Kaplancıklı ZA, Turan-Zitouni G, Özdemir A, İşcan G, Akalın G, Yıldırım Ş.. (2011) Synthesis and anticandidal activity of new triazolothiadiazine derivatives., 46 (11): [PMID:21959231] [10.1016/j.ejmech.2011.09.020] |
277. PubChem BioAssay data set, |
278. PubChem BioAssay data set, |
279. PubChem BioAssay data set, |
280. PubChem BioAssay data set, |
281. PubChem BioAssay data set, |
282. Polli JW, Wring SA, Humphreys JE, Huang L, Morgan JB, Webster LO, Serabjit-Singh CS.. (2001) Rational use of in vitro P-glycoprotein assays in drug discovery., 299 (2): [PMID:11602674] |
283. Scott S. Auerbach, DrugMatrix¨ and ToxFX¨ Coordinator National Toxicology Program. DrugMatrix in vitro pharmacology data, |
284. Chen M, Vijay V, Shi Q, Liu Z, Fang H, Tong W.. (2011) FDA-approved drug labeling for the study of drug-induced liver injury., 16 (15-16): [PMID:21624500] [10.1016/j.drudis.2011.05.007] |
285. Liu Z, Shi Q, Ding D, Kelly R, Fang H, Tong W.. (2011) Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps)., 7 (12): [PMID:22194678] [10.1371/journal.pcbi.1002310] |
286. Pardeshi S, Bobade VD.. (2011) Synthesis and biological evaluation of some novel triazol-3-ones as antimicrobial agents., 21 (21): [PMID:21920741] [10.1016/j.bmcl.2011.08.049] |
287. dos Santos MS, Oliveira ML, Bernardino AM, de Léo RM, Amaral VF, de Carvalho FT, Leon LL, Canto-Cavalheiro MM.. (2011) Synthesis and antileishmanial evaluation of 1-aryl-4-(4,5-dihydro-1H-imidazol-2-yl)-1H-pyrazole derivatives., 21 (24): [PMID:22055204] [10.1016/j.bmcl.2011.09.134] |
288. Murthy YL, Mallika D, Rajack A, Reddy GD.. (2011) A new antifungal briarane diterpenoid from the gorgonian Junceella juncea Pallas., 21 (24): [PMID:22071302] [10.1016/j.bmcl.2011.06.087] |
289. Liaras K, Geronikaki A, Glamočlija J, Cirić A, Soković M.. (2011) Novel (E)-1-(4-methyl-2-(alkylamino)thiazol-5-yl)-3-arylprop-2-en-1-ones as potent antimicrobial agents., 19 (24): [PMID:22079864] [10.1016/j.bmc.2011.10.059] |
290. Babu M, Pitchumani K, Ramesh P.. (2012) Isoxazoles incorporated N-substituted decahydroquinolines: a precursor to the next generation antimicrobial drug., 47 [PMID:22133458] [10.1016/j.ejmech.2011.10.045] |
291. Tani N, Rahnasto-Rilla M, Wittekindt C, Salminen KA, Ritvanen A, Ollakka R, Koskiranta J, Raunio H, Juvonen RO.. (2012) Antifungal activities of novel non-azole molecules against S. cerevisiae and C. albicans., 47 [PMID:22100140] [10.1016/j.ejmech.2011.10.053] |
292. Yamuna E, Kumar RA, Zeller M, Rajendra Prasad KJ.. (2012) Synthesis, antimicrobial, antimycobacterial and structure-activity relationship of substituted pyrazolo-, isoxazolo-, pyrimido- and mercaptopyrimidocyclohepta[b]indoles., 47 [PMID:22119150] [10.1016/j.ejmech.2011.10.046] |
293. McNulty J, Nair JJ, Vurgun N, Difrancesco BR, Brown CE, Tsoi B, Crankshaw DJ, Holloway AC.. (2012) Discovery of a novel class of aldol-derived 1,2,3-triazoles: potent and selective inhibitors of human cytochrome P450 19A1 (aromatase)., 22 (1): [PMID:22079757] [10.1016/j.bmcl.2011.10.039] |
294. Patel D, Kumari P, Patel N.. (2012) Synthesis and biological evaluation of some thiazolidinones as antimicrobial agents., 48 [PMID:22182927] [10.1016/j.ejmech.2011.11.041] |
295. Avupati VR, Yejella RP, Guntuku G, Gunta P.. (2012) Synthesis, characterization and in vitro biological evaluation of some novel diarylsulfonylureas as potential cytotoxic and antimicrobial agents., 22 (2): [PMID:22200598] [10.1016/j.bmcl.2011.11.125] |
296. Zoumpoulakis P, Camoutsis Ch, Pairas G, Soković M, Glamočlija J, Potamitis C, Pitsas A.. (2012) Synthesis of novel sulfonamide-1,2,4-triazoles, 1,3,4-thiadiazoles and 1,3,4-oxadiazoles, as potential antibacterial and antifungal agents. Biological evaluation and conformational analysis studies., 20 (4): [PMID:22264752] [10.1016/j.bmc.2011.12.031] |
297. Abdel-Wahab BF, Khidre RE, Awad GE.. (2012) Regioselective synthesis and antimicrobial activities of some novel aryloxyacetic acid derivatives., 50 [PMID:22373733] [10.1016/j.ejmech.2012.01.028] |
298. Bhaskar G, Arun Y, Balachandran C, Saikumar C, Perumal PT.. (2012) Synthesis of novel spirooxindole derivatives by one pot multicomponent reaction and their antimicrobial activity., 51 [PMID:22405285] [10.1016/j.ejmech.2012.02.024] |
299. PubChem BioAssay data set, |
300. Bonfield K, Amato E, Bankemper T, Agard H, Steller J, Keeler JM, Roy D, McCallum A, Paula S, Ma L.. (2012) Development of a new class of aromatase inhibitors: design, synthesis and inhibitory activity of 3-phenylchroman-4-one (isoflavanone) derivatives., 20 (8): [PMID:22444875] [10.1016/j.bmc.2012.02.042] |
301. Hille UE, Zimmer C, Haupenthal J, Hartmann RW.. (2011) Optimization of the First Selective Steroid-11β-hydroxylase (CYP11B1) Inhibitors for the Treatment of Cortisol Dependent Diseases., 2 (8): [PMID:24900349] [10.1021/ml100283h] |
302. Zou Y, Zhao Q, Liao J, Hu H, Yu S, Chai X, Xu M, Wu Q.. (2012) New triazole derivatives as antifungal agents: synthesis via click reaction, in vitro evaluation and molecular docking studies., 22 (8): [PMID:22437114] [10.1016/j.bmcl.2012.02.042] |
303. Abdel-Wahab BF, Abdel-Latif E, Mohamed HA, Awad GE.. (2012) Design and synthesis of new 4-pyrazolin-3-yl-1,2,3-triazoles and 1,2,3-triazol-4-yl-pyrazolin-1-ylthiazoles as potential antimicrobial agents., 52 [PMID:22480494] [10.1016/j.ejmech.2012.03.023] |
304. Patel RV, Patel PK, Kumari P, Rajani DP, Chikhalia KH.. (2012) Synthesis of benzimidazolyl-1,3,4-oxadiazol-2ylthio-N-phenyl (benzothiazolyl) acetamides as antibacterial, antifungal and antituberculosis agents., 53 [PMID:22516426] [10.1016/j.ejmech.2012.03.033] |
305. Kim HJ, Lee SH, Koh JS, Lee SH.. (2012) Preclinical metabolism of LB42908, a novel farnesyl transferase inhibitor, and its effects on the cytochrome P450 isozyme activities., 22 (9): [PMID:22497764] [10.1016/j.bmcl.2012.03.070] |
306. Muralikrishna A, Venkatesh BC, Padmavathi V, Padmaja A, Kondaiah P, Krishna NS.. (2012) Synthesis, antimicrobial and cytotoxic activities of sulfone linked bis heterocycles., 54 [PMID:22748281] [10.1016/j.ejmech.2012.06.014] |
307. Li C, La MP, Tang H, Pan WH, Sun P, Krohn K, Yi YH, Li L, Zhang W.. (2012) Bioactive briarane diterpenoids from the South China Sea gorgonian Dichotella gemmacea., 22 (13): [PMID:22647719] [10.1016/j.bmcl.2012.05.001] |
308. Zhang H, Zhou L, Amblard F, Shi J, Bobeck DR, Tao S, McBrayer TR, Tharnish PM, Whitaker T, Coats SJ, Schinazi RF.. (2012) Synthesis and evaluation of novel potent HCV NS5A inhibitors., 22 (14): [PMID:22704887] [10.1016/j.bmcl.2012.05.039] |
309. Hewitson KS, Vullo D, Scozzafava A, Mastrolorenzo A, Supuran CT.. (2012) Molecular cloning, characterization, and inhibition studies of a β-carbonic anhydrase from Malassezia globosa, a potential antidandruff target., 55 (7): [PMID:22424239] [10.1021/jm300203r] |
310. Alarif WM, Al-Lihaibi SS, Ayyad SE, Abdel-Rhman MH, Badria FA.. (2012) Laurene-type sesquiterpenes from the Red Sea red alga Laurencia obtusa as potential antitumor-antimicrobial agents., 55 [PMID:22819506] [10.1016/j.ejmech.2012.06.060] |
311. Sakatis MZ, Reese MJ, Harrell AW, Taylor MA, Baines IA, Chen L, Bloomer JC, Yang EY, Ellens HM, Ambroso JL, Lovatt CA, Ayrton AD, Clarke SE.. (2012) Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds., 25 (10): [PMID:22931300] [10.1021/tx300075j] |
312. Cvetkovic M, Leake B, Fromm MF, Wilkinson GR, Kim RB.. (1999) OATP and P-glycoprotein transporters mediate the cellular uptake and excretion of fexofenadine., 27 (1): [PMID:10421612] |
313. Ekins S, Kim RB, Leake BF, Dantzig AH, Schuetz EG, Lan LB, Yasuda K, Shepard RL, Winter MA, Schuetz JD, Wikel JH, Wrighton SA.. (2002) Three-dimensional quantitative structure-activity relationships of inhibitors of P-glycoprotein., 61 (1): [PMID:11961113] [10.1124/mol.61.5.964] |
314. Nagy H, Goda K, Fenyvesi F, Bacsó Z, Szilasi M, Kappelmayer J, Lustyik G, Cianfriglia M, Szabó G.. (2004) Distinct groups of multidrug resistance modulating agents are distinguished by competition of P-glycoprotein-specific antibodies., 315 (1): [PMID:14985103] [10.1016/j.bbrc.2004.01.156] |
315. Schwab D, Fischer H, Tabatabaei A, Poli S, Huwyler J.. (2003) Comparison of in vitro P-glycoprotein screening assays: recommendations for their use in drug discovery., 46 (9): [PMID:12699389] [10.1021/jm021012t] |
316. Wang EJ, Casciano CN, Clement RP, Johnson WW.. (2003) Fluorescent substrates of sister-P-glycoprotein (BSEP) evaluated as markers of active transport and inhibition: evidence for contingent unequal binding sites., 20 (1): [PMID:12739759] [10.1023/a:1023278211849] |
317. Takano M, Hasegawa R, Fukuda T, Yumoto R, Nagai J, Murakami T.. (1998) Interaction with P-glycoprotein and transport of erythromycin, midazolam and ketoconazole in Caco-2 cells., 358 (1): [PMID:9822896] [10.1016/s0014-2999(98)00607-4] |
318. Choo EF, Leake B, Wandel C, Imamura H, Wood AJ, Wilkinson GR, Kim RB.. (2000) Pharmacological inhibition of P-glycoprotein transport enhances the distribution of HIV-1 protease inhibitors into brain and testes., 28 (1): [PMID:10820137] |
319. Wang EJ, Casciano CN, Clement RP, Johnson WW.. (2001) Active transport of fluorescent P-glycoprotein substrates: evaluation as markers and interaction with inhibitors., 289 (1): [PMID:11716514] [10.1006/bbrc.2001.6000] |
320. Kim RB, Leake B, Cvetkovic M, Roden MM, Nadeau J, Walubo A, Wilkinson GR.. (1999) Modulation by drugs of human hepatic sodium-dependent bile acid transporter (sodium taurocholate cotransporting polypeptide) activity., 291 (1): [PMID:10565843] |
321. Wang EJ, Lew K, Casciano CN, Clement RP, Johnson WW.. (2002) Interaction of common azole antifungals with P glycoprotein., 46 (1): [PMID:11751127] [10.1128/aac.46.1.160-165.2002] |
322. Yasuda K, Lan LB, Sanglard D, Furuya K, Schuetz JD, Schuetz EG.. (2002) Interaction of cytochrome P450 3A inhibitors with P-glycoprotein., 303 (1): [PMID:12235267] [10.1124/jpet.102.037549] |
323. USP Dictionary of USAN and International Names (2010 edition) and USAN registrations 2007-date, |
324. Olivella M, Marchal A, Nogueras M, Sánchez A, Melguizo M, Raimondi M, Zacchino S, Giannini F, Cobo J, Enriz RD.. (2012) Structure-activity relationship study of nitrosopyrimidines acting as antifungal agents., 20 (20): [PMID:22995772] [10.1016/j.bmc.2012.08.033] |
325. Sun P, Meng LY, Tang H, Liu BS, Li L, Yi Y, Zhang W.. (2012) Sinularosides A and B, bioactive 9,11-secosteroidal glycosides from the South China Sea soft coral Sinularia humilis Ofwegen., 75 (9): [PMID:22946634] [10.1021/np300475d] |
326. Padmavathi V, Prema Kumari C, Venkatesh BC, Padmaja A.. (2011) Synthesis and antimicrobial activity of amido linked pyrrolyl and pyrazolyl-oxazoles, thiazoles and imidazoles., 46 (11): [PMID:21906854] [10.1016/j.ejmech.2011.08.032] |
327. Avupati VR, Yejella RP, Akula A, Guntuku GS, Doddi BR, Vutla VR, Anagani SR, Adimulam LS, Vyricharla AK.. (2012) Synthesis, characterization and biological evaluation of some novel 2,4-thiazolidinediones as potential cytotoxic, antimicrobial and antihyperglycemic agents., 22 (20): [PMID:22981328] [10.1016/j.bmcl.2012.08.052] |
328. Kouznetsov VV, Meléndez Gómez CM, Derita MG, Svetaz L, del Olmo E, Zacchino SA.. (2012) Synthesis and antifungal activity of diverse C-2 pyridinyl and pyridinylvinyl substituted quinolines., 20 (21): [PMID:23036332] [10.1016/j.bmc.2012.08.036] |
329. Karlgren M, Vildhede A, Norinder U, Wisniewski JR, Kimoto E, Lai Y, Haglund U, Artursson P.. (2012) Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions., 55 (10): [PMID:22541068] [10.1021/jm300212s] |
330. Chen L, Conda-Sheridan M, Reddy PV, Morrell A, Park EJ, Kondratyuk TP, Pezzuto JM, van Breemen RB, Cushman M.. (2012) Identification, synthesis, and biological evaluation of the metabolites of 3-amino-6-(3'-aminopropyl)-5H-indeno[1,2-c]isoquinoline-5,11-(6H)dione (AM6-36), a promising rexinoid lead compound for the development of cancer chemotherapeutic and chemopreventive agents., 55 (12): [PMID:22712432] [10.1021/jm3006806] |
331. Altıntop MD, Özdemir A, Turan-Zitouni G, Ilgın S, Atlı Ö, İşcan G, Kaplancıklı ZA.. (2012) Synthesis and biological evaluation of some hydrazone derivatives as new anticandidal and anticancer agents., 58 [PMID:23142671] [10.1016/j.ejmech.2012.10.011] |
332. Bakmiwewa SM, Fatokun AA, Tran A, Payne RJ, Hunt NH, Ball HJ.. (2012) Identification of selective inhibitors of indoleamine 2,3-dioxygenase 2., 22 (24): [PMID:23122865] [10.1016/j.bmcl.2012.10.010] |
333. Aytemir MD, Ozcelik B. (2011) Synthesis and biological activities of new Mannich bases of chlorokojic acid derivatives, 20 (4): [10.1007/s00044-010-9338-x] |
334. Altundas A, Ayvaz S, Logoglu E. (2011) Synthesis and evaluation of a series of aminocyanopyridines as antimicrobial agents, 20 (1): [10.1007/s00044-009-9273-x] |
335. Sedaghati B, Fassihi A, Arbabi S, Ranjbar M, Memarian HR, Saghaie L, Omidi A, Sardari A, Jalali M, Abedi D. (2012) Synthesis and antimicrobial activity of novel derivatives of Biginelli pyrimidines, 21 (12): [10.1007/s00044-011-9931-7] |
336. Amir M, Javed SA, Zaheen Hassan M. (2012) Synthesis and antimicrobial activity of pyrazolinones and pyrazoles having benzothiazole moiety, 21 (7): [10.1007/s00044-011-9642-0] |
337. Alegaon SG, Alagawadi KR. (2012) New thiazolidine-2,4-diones as antimicrobial and cytotoxic agent, 21 (10): [10.1007/s00044-011-9876-x] |
338. Abdel-Wahab BF, Abdel-Gawad H, Awad GEA, Badria FA. (2012) Synthesis, antimicrobial, antioxidant, anti-inflammatory, and analgesic activities of some new 3-(2-thienyl)pyrazole-based heterocycles, 21 (7): [10.1007/s00044-011-9661-x] |
339. Kocyigit-Kaymakcoglu B, Oruc-Emre EE, Unsalan S, Tabanca N, Khan SI, Wedge DE, Iscan G, Demirci F, Rollas S. (2012) Synthesis and biological activity of hydrazidehydrazones and their corresponding 3-acetyl-2,5-disubstituted-2,3-dihydro-1,3,4-oxadiazoles, 21 (11): [10.1007/s00044-011-9882-z] |
340. Patel D, Kumari P, Patel N. (2012) Synthesis of 3-{4-[4-dimethylamino-6-(4-methyl-2-oxo-2H-chromen-7-yloxy)-[1,3,5]triazin-2-ylamino]-phenyl}-2-phenyl-5-(4-pyridin-2-yl-piperazin-1-ylmethyl)-thiazolidin-4-one and their biological evaluation, 21 (10): [10.1007/s00044-011-9822-y] |
341. Tunal Y, Karaca H, Iscan G, Demirci F, Benkli K. (2012) Antibacterial and antifungal activities of some trimethoprim salts, 21 (6): [10.1007/s00044-011-9605-5] |
342. Patel D, Patel R, Kumari P, Patel N. (2012) In vitro antimicrobial assessment of coumarin-based s-triazinyl piperazines, 21 (8): [10.1007/s00044-011-9676-3] |
343. Laxmi SV, Janardhan B, Rajitha B, Raghavaiah P, Srinivas P. (2012) Synthesis, single crystal X-ray studies and antimicrobial activities of novel Indole barbiturates, 21 (10): [10.1007/s00044-011-9827-6] |
344. Al-kaissi EN, Al-Ghrary NF, Al-Kaisi NK, Al-Shamma A, Muhi-eldeen Z. (2012) Synthesis and antimicrobial evaluation of 4,5-diaryl-2-[4-(t-amino)-2-butynyl]-2,4-dihydro-3H-1,2,4-triazol-3-ones, 21 (11): [10.1007/s00044-011-9840-9] |
345. Patel RV, Patel AB, Kumari P, Chikhalia KH. (2012) Synthesis of novel 3-(5-sulfanyl-1,3,4-oxadiazol-2-yl)-2H-chromen-2-one condensed s-triazinyl piperazines and piperidines as antimicrobial agents, 21 (10): [10.1007/s00044-011-9842-7] |
346. Patel PK, Patel RV, Mahajan DH, Parikh PA, Mehta GN, Chikhalia KH. (2012) Design, synthesis, characterization, and in vitro antimicrobial action of novel trisubstituted s-triazines, 21 (10): [10.1007/s00044-011-9849-0] |
347. Labbé C, Faini F, Villagrán C, Coll J, Rycroft DS.. (2005) Antifungal and insect antifeedant 2-phenylethanol esters from the liverwort Balantiopsis cancellata from Chile., 53 (2): [PMID:15656657] [10.1021/jf048935c] |
348. Bansode S, Kamble R. (2012) Synthesis of novel 2-(3-aryl-sydnon-4-ylidene)-5-substituted-[1,3,4]-thiadiazolylamines and [1,3,4]-thiadiazol-2-yl-3-oxo-[1,2,4]-triazoles as antimicrobial agents, 21 (6): [10.1007/s00044-011-9596-2] |
349. Alegaon SG, Alagawadi KR. (2012) New thiazolidinedione-5-acetic acid amide derivatives: synthesis, characterization and investigation of antimicrobial and cytotoxic properties, 21 (6): [10.1007/s00044-011-9598-0] |
350. Jimenez F, Cruz MdC, Zuniga C, Martinez MA, Chamorro G, Diaz F, Tamariz J. (2010) Aryloxyacetic esters structurally related to -Asarone as potential antifungal agents, 19 (1): [10.1007/s00044-009-9170-3] |
351. Sahoo PK, Sharma R, Pattanayak P. (2010) Synthesis and evaluation of 4-amino-5-phenyl-4H-[1,2,4]-triazole-3-thiol derivatives as antimicrobial agents, 19 (2): [10.1007/s00044-009-9178-8] |
352. Kaya M, Yldrr Y, Celik GY. (2011) Synthesis and antimicrobial activities of novel bisacridine-1,8-dione derivatives, 20 (3): [10.1007/s00044-010-9321-6] |
353. Katrcoglu H, Logoglu E, Tilki T, Oktemer A. (2007) Synthesis of 2,4-dihalogenofluorobenzenes and their antimicrobial and antifungal activity studies, 16 (5): [10.1007/s00044-007-9024-9] |
354. Svetaz L, Tapia A, López SN, Furlán RL, Petenatti E, Pioli R, Schmeda-Hirschmann G, Zacchino SA.. (2004) Antifungal chalcones and new caffeic acid esters from Zuccagnia punctata acting against soybean infecting fungi., 52 (11): [PMID:15161186] [10.1021/jf035213x] |
355. Camoutsis C, Geronikaki A, Ciric A, Soković M, Zoumpoulakis P, Zervou M.. (2010) Sulfonamide-1,2,4-thiadiazole derivatives as antifungal and antibacterial agents: synthesis, biological evaluation, lipophilicity, and conformational studies., 58 (2): [PMID:20118573] [10.1248/cpb.58.160] |
356. Saravanan G, Alagarsamy V, Prakash CR. (2013) Synthesis, analgesic, anti-inflammatory, and in vitro antimicrobial activities of some novel quinazolin-4(3H)-one derivatives, 22 (1): [10.1007/s00044-012-0037-7] |
357. Patel AB, Patel RV, Kumari P, Rajani DP, Chikhalia KH. (2013) Synthesis of potential antitubercular and antimicrobial s-triazine-based scaffolds via Suzuki cross-coupling reaction, 22 (1): [10.1007/s00044-012-0041-y] |
358. Mistry BM, Jauhari S. (2013) Synthesis and in vitro antimicrobial and anti-tubercular evaluation of some quinoline-based azitidinone and thiazolidinone analogues, 22 (2): [10.1007/s00044-012-0060-8] |
359. Mistry BM, Jauhari S. (2013) Quinoline-based azetidinone and thiazolidinone analogues as antimicrobial and antituberculosis agents, 22 (2): [10.1007/s00044-012-0061-7] |
360. Patel D, Kumari P, Patel NB. (2013) In vitro antimicrobial and antimycobacterial activity of some chalcones and their derivatives, 22 (2): [10.1007/s00044-012-0073-3] |
361. Ozkay Y, Incesu Z, Onder NI, Tunal Y, Karaca H, Iskdag I, Ucucu U. (2013) Antimicrobial and anticancer effects of some 2-(substitutedsulfanyl)-N-(5-methyl-isoxazol-3-yl)acetamide derivatives, 22 (1): [10.1007/s00044-012-0021-2] |
362. Patel RV, Kumari P, Rajani DP, Chikhalia KH. (2013) Synthesis of coumarin-based 1,3,4-oxadiazol-2ylthio-N-phenyl/benzothiazolyl acetamides as antimicrobial and antituberculosis agents, 22 (1): [10.1007/s00044-012-0026-x] |
363. Opletalová V, Hartl J, Patel A, Palát K, Buchta V.. (2002) Ring substituted 3-phenyl-1-(2-pyrazinyl)-2-propen-1-ones as potential photosynthesis-inhibiting, antifungal and antimycobacterial agents., 57 (2): [PMID:11902656] [10.1016/s0014-827x(01)01187-9] |
364. Bhat MA, Al-Omar MA, Siddiqui N. (2013) Antimicrobial activity of Schiff bases of coumarin-incorporated 1,3,4-oxadiazole derivatives: an in vitro evaluation, 22 (9): [10.1007/s00044-012-0452-9] |
365. Vanparia SF, Patel TS, Dixit RB, Dixit BC. (2013) Synthesis and in vitro antimicrobial activity of some newer quinazolinonesulfonamide linked hybrid heterocyclic entities derived from glycine, 22 (11): [10.1007/s00044-012-0320-7] |
366. Karunai Raj M, Balachandran C, Duraipandiyan V, Agastian P, Ignacimuthu S, Vijayakumar A. (2013) Isolation of terrestribisamide from Peltophorum pterocarpum (DC.) Baker ex. K. Heyne and its antimicrobial, antioxidant, and cytotoxic activities, 22 (8): [10.1007/s00044-012-0393-3] |
367. Kashid AM, Dube PN, Alkutkar PG, Bothara KG, Mokale SN, Dhawale SC. (2013) Synthesis, biological screening and ADME prediction of benzylindole derivatives as novel anti-HIV-1, anti-fungal and anti-bacterial agents, 22 (10): [10.1007/s00044-012-0463-6] |
368. Babu M, Pitchumani K, Ramesh P. (2013) Synthesis and antimicrobial activities of highly functionalised novel -lactam and thiazolidine-grafted tetrahydrobenzothiophenes, 22 (6): [10.1007/s00044-012-0259-8] |
369. Apostolidis I, Liaras K, Geronikaki A, Hadjipavlou-Litina D, Gavalas A, Soković M, Glamočlija J, Ćirić A.. (2013) Synthesis and biological evaluation of some 5-arylidene-2-(1,3-thiazol-2-ylimino)-1,3-thiazolidin-4-ones as dual anti-inflammatory/antimicrobial agents., 21 (2): [PMID:23219856] [10.1016/j.bmc.2012.10.046] |
370. PubChem BioAssay data set, |
371. Arun Y, Bhaskar G, Balachandran C, Ignacimuthu S, Perumal PT.. (2013) Facile one-pot synthesis of novel dispirooxindole-pyrrolidine derivatives and their antimicrobial and anticancer activity against A549 human lung adenocarcinoma cancer cell line., 23 (6): [PMID:23395665] [10.1016/j.bmcl.2013.01.023] |
372. Amblard F, Zhang H, Zhou L, Shi J, Bobeck DR, Nettles JH, Chavre S, McBrayer TR, Tharnish P, Whitaker T, Coats SJ, Schinazi RF.. (2013) Synthesis and evaluation of non-dimeric HCV NS5A inhibitors., 23 (7): [PMID:23466233] [10.1016/j.bmcl.2013.02.023] |
373. Abbas SY, El-Sharief MA, Basyouni WM, Basyouni WM, Fakhr IM, El-Gammal EW.. (2013) Thiourea derivatives incorporating a hippuric acid moiety: synthesis and evaluation of antibacterial and antifungal activities., 64 [PMID:23644194] [10.1016/j.ejmech.2013.04.002] |
374. Wang QX, Yang JL, Qi QY, Bao L, Yang XL, Liu MM, Huang P, Zhang LX, Chen JL, Cai L, Liu HW.. (2013) 3-Anhydro-6-hydroxy-ophiobolin A, a new sesterterpene inhibiting the growth of methicillin-resistant Staphylococcus aureus and inducing the cell death by apoptosis on K562, from the phytopathogenic fungus Bipolaris oryzae., 23 (12): [PMID:23668986] [10.1016/j.bmcl.2013.04.034] |
375. Althagafy HS, Graf TN, Sy-Cordero AA, Gufford BT, Paine MF, Wagoner J, Polyak SJ, Croatt MP, Oberlies NH.. (2013) Semisynthesis, cytotoxicity, antiviral activity, and drug interaction liability of 7-O-methylated analogues of flavonolignans from milk thistle., 21 (13): [PMID:23673225] [10.1016/j.bmc.2013.04.017] |
376. Emami S, Shojapour S, Faramarzi MA, Samadi N, Irannejad H.. (2013) Synthesis, in vitro antifungal activity and in silico study of 3-(1,2,4-triazol-1-yl)flavanones., 66 [PMID:23831810] [10.1016/j.ejmech.2013.06.008] |
377. Wang XD, Deng RC, Dong JJ, Peng ZY, Gao XM, Li ST, Lin WQ, Lu CL, Xiao ZP, Zhu HL.. (2013) 3-Aryl-4-acyloxyethoxyfuran-2(5H)-ones as inhibitors of tyrosyl-tRNA synthetase: synthesis, molecular docking and antibacterial evaluation., 21 (17): [PMID:23891164] [10.1016/j.bmc.2013.06.066] |
378. El-Sharief MA, Abbas SY, El-Bayouki KA, El-Bayouki KA, El-Gammal EW.. (2013) Synthesis of thiosemicarbazones derived from N-(4-hippuric acid)thiosemicarbazide and different carbonyl compounds as antimicrobial agents., 67 [PMID:23871906] [10.1016/j.ejmech.2013.06.031] |
379. Desai NC, Bhatt N, Somani H, Trivedi A.. (2013) Synthesis, antimicrobial and cytotoxic activities of some novel thiazole clubbed 1,3,4-oxadiazoles., 67 [PMID:23835482] [10.1016/j.ejmech.2013.06.029] |
380. Garrido M, Cabeza M, Cortés F, Gutiérrez J, Bratoeff E.. (2013) Cytotoxic effect of novel dehydroepiandrosterone derivatives on different cancer cell lines., 68 [PMID:23994323] [10.1016/j.ejmech.2013.02.031] |
381. Desai NC, Pandya DD, Kotadiya GM, Desai P. (2013) Synthesis, antimicrobial and cytotoxic activity of 2-azetidinone derivatives of pyridyl benzimidazoles, [10.1007/s00044-013-0775-1] |
382. Choi JY, Calvet CM, Gunatilleke SS, Ruiz C, Cameron MD, McKerrow JH, Podust LM, Roush WR.. (2013) Rational development of 4-aminopyridyl-based inhibitors targeting Trypanosoma cruzi CYP51 as anti-chagas agents., 56 (19): [PMID:24079662] [10.1021/jm401067s] |
383. Sykes ML, Avery VM.. (2013) Approaches to protozoan drug discovery: phenotypic screening., 56 (20): [PMID:23927763] [10.1021/jm4004279] |
384. Unpublished dataset, |
385. Unpublished dataset, |
386. Unpublished dataset, |
387. De Bruyn T, van Westen GJ, Ijzerman AP, Stieger B, de Witte P, Augustijns PF, Annaert PP.. (2013) Structure-based identification of OATP1B1/3 inhibitors., 83 (6): [PMID:23571415] [10.1124/mol.112.084152] |
388. Akbaş H, Okumuş A, Kılıç Z, Hökelek T, Süzen Y, Koç LY, Açık L, Celik ZB.. (2013) Phosphorus-nitrogen compounds part 27. Syntheses, structural characterizations, antimicrobial and cytotoxic activities, and DNA interactions of new phosphazenes bearing secondary amino and pendant (4-fluorobenzyl)spiro groups., 70 [PMID:24161706] [10.1016/j.ejmech.2013.09.046] |
389. Kovács D, Wölfling J, Szabó N, Szécsi M, Kovács I, Zupkó I, Frank E.. (2013) An efficient approach to novel 17-5'-(1',2',4')-oxadiazolyl androstenes via the cyclodehydration of cytotoxic O-steroidacylamidoximes, and an evaluation of their inhibitory action on 17α-hydroxylase/C₁₇,₂₀-lyase., 70 [PMID:24211641] [10.1016/j.ejmech.2013.10.038] |
390. Cai G, Napolitano JG, McAlpine JB, Wang Y, Jaki BU, Suh JW, Yang SH, Lee IA, Franzblau SG, Pauli GF, Cho S.. (2013) Hytramycins V and I, anti-Mycobacterium tuberculosis hexapeptides from a Streptomyces hygroscopicus strain., 76 (11): [PMID:24224794] [10.1021/np400145u] |
391. Yurttaş L, Duran M, Demirayak Ş, Gençer HK, Tunalı Y.. (2013) Synthesis and initial biological evaluation of substituted 1-phenylamino-2-thio-4,5-dimethyl-1H-imidazole derivatives., 23 (24): [PMID:24176398] [10.1016/j.bmcl.2013.10.024] |
392. Gu W, Qiao C, Wang SF, Hao Y, Miao TT.. (2014) Synthesis and biological evaluation of novel N-substituted 1H-dibenzo[a,c]carbazole derivatives of dehydroabietic acid as potential antimicrobial agents., 24 (1): [PMID:24300736] [10.1016/j.bmcl.2013.11.009] |
393. Li L, Ding H, Wang B, Yu S, Zou Y, Chai X, Wu Q.. (2014) Synthesis and evaluation of novel azoles as potent antifungal agents., 24 (1): [PMID:24332489] [10.1016/j.bmcl.2013.11.037] |
394. Maltais R, Ayan D, Trottier A, Barbeau X, Lagüe P, Bouchard JE, Poirier D.. (2014) Discovery of a non-estrogenic irreversible inhibitor of 17β-hydroxysteroid dehydrogenase type 1 from 3-substituted-16β-(m-carbamoylbenzyl)-estradiol derivatives., 57 (1): [PMID:24328103] [10.1021/jm401639v] |
395. Zou Y, Yu S, Li R, Zhao Q, Li X, Wu M, Huang T, Chai X, Hu H, Wu Q.. (2014) Synthesis, antifungal activities and molecular docking studies of novel 2-(2,4-difluorophenyl)-2-hydroxy-3-(1H-1,2,4-triazol-1-yl)propyl dithiocarbamates., 74 [PMID:24487187] [10.1016/j.ejmech.2014.01.009] |
396. Lavanya G, Mallikarjuna Reddy L, Padmavathi V, Padmaja A.. (2014) Synthesis and antimicrobial activity of (1,4-phenylene)bis(arylsulfonylpyrazoles and isoxazoles)., 73 [PMID:24398288] [10.1016/j.ejmech.2013.11.041] |
397. Bae IH, Choi JK, Chough C, Keum SJ, Kim H, Jang SK, Kim BM.. (2014) Potent Hepatitis C Virus NS5A Inhibitors Containing a Benzidine Core., 5 (3): [PMID:24900814] [10.1021/ml4003293] |
398. Altıntop MD, Kaplancıklı ZA, Ciftçi GA, Demirel R.. (2014) Synthesis and biological evaluation of thiazoline derivatives as new antimicrobial and anticancer agents., 74 [PMID:24480358] [10.1016/j.ejmech.2013.12.060] |
399. Schrekker HS, Donato RK, Fuentefria AM, Bergamo V, Oliveira LF, Machado MM. (2013) Imidazolium salts as antifungal agents: activity against emerging yeast pathogens, without human leukocyte toxicity, 4 (11): [10.1039/C3MD00222E] |
400. Biour M, Ben Salem C, Chazouillères O, Grangé JD, Serfaty L, Poupon R.. (2004) [Drug-induced liver injury; fourteenth updated edition of the bibliographic database of liver injuries and related drugs]., 28 (8-9): [PMID:15646539] [10.1016/s0399-8320(04)95062-2] |
401. Yu S, Chai X, Wang N, Cui H, Zhao Q, Hu H, Zou Y, Sun Q, Wu Q. (2013) Synthesis and antifungal activity of the novel triazole compounds, 4 (4): [10.1039/C3MD20086H] |
402. Mateus A, Matsson P, Artursson P.. (2014) A high-throughput cell-based method to predict the unbound drug fraction in the brain., 57 (7): [PMID:24601604] [10.1021/jm401963n] |
403. Seenaiah D, Reddy PR, Reddy GM, Padmaja A, Padmavathi V, Krishna NS.. (2014) Synthesis, antimicrobial and cytotoxic activities of pyrimidinyl benzoxazole, benzothiazole and benzimidazole., 77 [PMID:24607584] [10.1016/j.ejmech.2014.02.050] |
404. Heeres J, Backx LJ, Mostmans JH, Van Cutsem J.. (1979) Antimycotic imidazoles. part 4. Synthesis and antifungal activity of ketoconazole, a new potent orally active broad-spectrum antifungal agent., 22 (8): [PMID:490531] [10.1021/jm00194a023] |
405. Suchaud V, Bailly F, Lion C, Calmels C, Andréola ML, Christ F, Debyser Z, Cotelle P.. (2014) Investigation of a novel series of 2-hydroxyisoquinoline-1,3(2H,4H)-diones as human immunodeficiency virus type 1 integrase inhibitors., 57 (11): [PMID:24793360] [10.1021/jm500109z] |
406. Sudhapriya N, Perumal PT, Balachandran C, Ignacimuthu S, Sangeetha M, Doble M.. (2014) Synthesis of new class of spirocarbocycle derivatives by multicomponent domino reaction and their evaluation for antimicrobial, anticancer activity and molecular docking studies., 83 [PMID:24956555] [10.1016/j.ejmech.2014.05.065] |
407. Łażewska D, Więcek M, Ner J, Kamińska K, Kottke T, Schwed JS, Zygmunt M, Karcz T, Olejarz A, Kuder K, Latacz G, Grosicki M, Sapa J, Karolak-Wojciechowska J, Stark H, Kieć-Kononowicz K.. (2014) Aryl-1,3,5-triazine derivatives as histamine H4 receptor ligands., 83 [PMID:24996140] [10.1016/j.ejmech.2014.06.032] |
408. Bhanu Prakash T, Dinneswara Reddy G, Padmaja A, Padmavathi V.. (2014) Synthesis and antimicrobial activity of amine linked bis- and tris-heterocycles., 82 [PMID:24929288] [10.1016/j.ejmech.2014.06.001] |
409. Chávez-Riveros A, Garrido M, Ramírez Apan MT, Zambrano A, Díaz M, Bratoeff E.. (2014) Synthesis and cytotoxic effect on cancer cell lines and macrophages of novel progesterone derivatives having an ester or a carbamate function at C-3 and C-17., 82 [PMID:24937183] [10.1016/j.ejmech.2014.06.008] |
410. Xu DX, Sun P, Kurtán T, Mándi A, Tang H, Liu B, Gerwick WH, Wang ZW, Zhang W.. (2014) Polyhydroxy cyclohexanols from a Dendrodochium sp. fungus associated with the sea cucumber Holothuria nobilis Selenka., 77 (5): [PMID:24749951] [10.1021/np500024r] |
411. Mark Wenlock and Nicholas Tomkinson. Experimental in vitro DMPK and physicochemical data on a set of publicly disclosed compounds, [10.6019/CHEMBL3301361] |
412. Hu Q, Yin L, Hartmann RW.. (2014) Aldosterone synthase inhibitors as promising treatments for mineralocorticoid dependent cardiovascular and renal diseases., 57 (12): [PMID:24422519] [10.1021/jm401430e] |
413. Han M, Song C, Jeong N, Hahn HG.. (2014) Exploration of 3-Aminoazetidines as Triple Reuptake Inhibitors by Bioisosteric Modification of 3-α-Oxyazetidine., 5 (9): [PMID:25221656] [10.1021/ml500187a] |
414. McEneny-King A, Edginton AN, Rao PP.. (2015) Investigating the binding interactions of the anti-Alzheimer's drug donepezil with CYP3A4 and P-glycoprotein., 25 (2): [PMID:25499431] [10.1016/j.bmcl.2014.11.046] |
415. Park EJ, Ahn YG, Jung SH, Bang HJ, Kim M, Hong DJ, Kim J, Suh KH, Kim YJ, Kim D, Kim EY, Lee K, Min KH.. (2014) Discovery of novel pyrimidine and malonamide derivatives as TGR5 agonists., 24 (17): [PMID:25082126] [10.1016/j.bmcl.2014.07.026] |
416. Bratoeff E, Garrido M, Ramírez-Apan T, Heuze Y, Sánchez A, Soriano J, Cabeza M.. (2014) Effect of dehydroepiandrosterone derivatives on the activity of 5α-reductase isoenzymes and on cancer cell line PC-3., 22 (21): [PMID:25261928] [10.1016/j.bmc.2014.08.019] |
417. Chennakesava Rao K, Arun Y, Easwaramoorthi K, Balachandran C, Prakasam T, Eswara Yuvaraj T, Perumal PT.. (2014) Synthesis, antimicrobial and molecular docking studies of enantiomerically pure N-alkylated β-amino alcohols from phenylpropanolamines., 24 (14): [PMID:24894558] [10.1016/j.bmcl.2014.05.027] |
418. Yun J, Han M, Song C, Cheon SH, Choi K, Hahn HG.. (2014) Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors., 24 (15): [PMID:24974340] [10.1016/j.bmcl.2014.06.026] |
419. Röhrig UF, Majjigapu SR, Chambon M, Bron S, Pilotte L, Colau D, Van den Eynde BJ, Turcatti G, Vogel P, Zoete V, Michielin O.. (2014) Detailed analysis and follow-up studies of a high-throughput screening for indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors., 84 [PMID:25036789] [10.1016/j.ejmech.2014.06.078] |
420. Ferla S, Gomaa MS, Brancale A, Zhu J, Ochalek JT, DeLuca HF, Simons C.. (2014) Novel styryl-indoles as small molecule inhibitors of 25-hydroxyvitamin D-24-hydroxylase (CYP24A1): Synthesis and biological evaluation., 87 [PMID:25240094] [10.1016/j.ejmech.2014.09.035] |
421. Stefanachi A, Hanke N, Pisani L, Leonetti F, Nicolotti O, Catto M, Cellamare S, Hartmann RW, Carotti A.. (2015) Discovery of new 7-substituted-4-imidazolylmethyl coumarins and 4'-substituted-2-imidazolyl acetophenones open analogues as potent and selective inhibitors of steroid-11β-hydroxylase., 89 [PMID:25462231] [10.1016/j.ejmech.2014.10.021] |
422. Ayan D, Maltais R, Hospital A, Poirier D.. (2014) Chemical synthesis, cytotoxicity, selectivity and bioavailability of 5α-androstane-3α,17β-diol derivatives., 22 (21): [PMID:25300820] [10.1016/j.bmc.2014.09.026] |
423. Ferla S, Aboraia AS, Brancale A, Pepper CJ, Zhu J, Ochalek JT, DeLuca HF, Simons C.. (2014) Small-molecule inhibitors of 25-hydroxyvitamin D-24-hydroxylase (CYP24A1): synthesis and biological evaluation., 57 (18): [PMID:25148392] [10.1021/jm5009314] |
424. Schroeder CE, Yao T, Sotsky J, Smith RA, Roy S, Chu YK, Guo H, Tower NA, Noah JW, McKellip S, Sosa M, Rasmussen L, Smith LH, White EL, Aubé J, Jonsson CB, Chung D, Golden JE.. (2014) Development of (E)-2-((1,4-dimethylpiperazin-2-ylidene)amino)-5-nitro-N-phenylbenzamide, ML336: Novel 2-amidinophenylbenzamides as potent inhibitors of venezuelan equine encephalitis virus., 57 (20): [PMID:25244572] [10.1021/jm501203v] |
425. Kathirvelan D, Haribabu J, Reddy BS, Balachandran C, Duraipandiyan V.. (2015) Facile and diastereoselective synthesis of 3,2'-spiropyrrolidine-oxindoles derivatives, their molecular docking and antiproliferative activities., 25 (2): [PMID:25435149] [10.1016/j.bmcl.2014.10.099] |
426. Gu W, Hao Y, Zhang G, Wang SF, Miao TT, Zhang KP.. (2015) Synthesis, in vitro antimicrobial and cytotoxic activities of new carbazole derivatives of ursolic acid., 25 (3): [PMID:25537271] [10.1016/j.bmcl.2014.12.021] |
427. Cross RM, Flanigan DL, Monastyrskyi A, LaCrue AN, Sáenz FE, Maignan JR, Mutka TS, White KL, Shackleford DM, Bathurst I, Fronczek FR, Wojtas L, Guida WC, Charman SA, Burrows JN, Kyle DE, Manetsch R.. (2014) Orally bioavailable 6-chloro-7-methoxy-4(1H)-quinolones efficacious against multiple stages of Plasmodium., 57 (21): [PMID:25148516] [10.1021/jm500942v] |
428. Elmas G, Okumuş A, Koç LY, Soltanzade H, Kılıç Z, Hökelek T, Dal H, Açık L, Üstündağ Z, Dündar D, Yavuz M.. (2014) Phosphorus-nitrogen compounds. Part 29. Syntheses, crystal structures, spectroscopic and stereogenic properties, electrochemical investigations, antituberculosis, antimicrobial and cytotoxic activities and DNA interactions of ansa-spiro-ansa cyclotetraphosphazenes., 87 [PMID:25305333] [10.1016/j.ejmech.2014.10.005] |
429. Kaiser M, Mäser P, Tadoori LP, Ioset JR, Brun R.. Antiprotozoal Activity Profiling of Approved Drugs: A Starting Point toward Drug Repositioning, [10.6019/CHEMBL3392926] |
430. Grombein CM, Hu Q, Rau S, Zimmer C, Hartmann RW.. (2015) Heteroatom insertion into 3,4-dihydro-1H-quinolin-2-ones leads to potent and selective inhibitors of human and rat aldosterone synthase., 90 [PMID:25528333] [10.1016/j.ejmech.2014.12.022] |
431. Kamiński K, Rapacz A, Łuszczki JJ, Latacz G, Obniska J, Kieć-Kononowicz K, Filipek B.. (2015) Design, synthesis and biological evaluation of new hybrid anticonvulsants derived from N-benzyl-2-(2,5-dioxopyrrolidin-1-yl)propanamide and 2-(2,5-dioxopyrrolidin-1-yl)butanamide derivatives., 23 (10): [PMID:25868743] [10.1016/j.bmc.2015.03.038] |
432. Altıntop MD, Özdemir A, Turan-Zitouni G, Ilgın S, Atlı Ö, Demirel R, Kaplancıklı ZA.. (2015) A novel series of thiazolyl-pyrazoline derivatives: synthesis and evaluation of antifungal activity, cytotoxicity and genotoxicity., 92 [PMID:25576739] [10.1016/j.ejmech.2014.12.055] |
433. Njar VC, Brodie AM.. (2015) Discovery and development of Galeterone (TOK-001 or VN/124-1) for the treatment of all stages of prostate cancer., 58 (5): [PMID:25591066] [10.1021/jm501239f] |
434. Chinnababu B, Purushotham Reddy S, Sankara Rao P, Loka Reddy V, Sudheer Kumar B, Rao JV, Prakasham RS, Suresh Babu K.. (2015) Isolation, semi-synthesis and bio-evaluation of spatane derivatives from the brown algae Stoechospermum marginatum., 25 (12): [PMID:25978960] [10.1016/j.bmcl.2015.04.061] |
435. Lau AJ, Yang G, Rajaraman G, Baucom CC, Chang TK.. (2012) Species-dependent and receptor-selective action of bilobalide on the function of constitutive androstane receptor and pregnane X receptor., 40 (1): [PMID:22019630] [10.1124/dmd.111.042879] |
436. Lin X, Skolnik S, Chen X, Wang J.. (2011) Attenuation of intestinal absorption by major efflux transporters: quantitative tools and strategies using a Caco-2 model., 39 (2): [PMID:21051535] [10.1124/dmd.110.034629] |
437. Lee CA, Jones JP, Katayama J, Kaspera R, Jiang Y, Freiwald S, Smith E, Walker GS, Totah RA.. (2012) Identifying a selective substrate and inhibitor pair for the evaluation of CYP2J2 activity., 40 (5): [PMID:22328583] [10.1124/dmd.111.043505] |
438. Dawson S, Stahl S, Paul N, Barber J, Kenna JG.. (2012) In vitro inhibition of the bile salt export pump correlates with risk of cholestatic drug-induced liver injury in humans., 40 (1): [PMID:21965623] [10.1124/dmd.111.040758] |
439. Zhou J, Tracy TS, Remmel RP.. (2011) Correlation between bilirubin glucuronidation and estradiol-3-gluronidation in the presence of model UDP-glucuronosyltransferase 1A1 substrates/inhibitors., 39 (2): [PMID:21030469] [10.1124/dmd.110.035030] |
440. Arico-Muendel CC, Belanger B, Benjamin D, Blanchette HS, Caiazzo TM, Centrella PA, DeLorey J, Doyle EG, Gradhand U, Griffin ST, Hill S, Labenski MT, Morgan BA, O'Donovan G, Prasad K, Skinner S, Taghizadeh N, Thompson CD, Wakefield J, Westlin W, White KF.. (2013) Metabolites of PPI-2458, a selective, irreversible inhibitor of methionine aminopeptidase-2: structure determination and in vivo activity., 41 (4): [PMID:23355637] [10.1124/dmd.112.048355] |
441. Henne KR, Tran TB, VandenBrink BM, Rock DA, Aidasani DK, Subramanian R, Mason AK, Stresser DM, Teffera Y, Wong SG, Johnson MG, Chen X, Tonn GR, Wong BK.. (2012) Sequential metabolism of AMG 487, a novel CXCR3 antagonist, results in formation of quinone reactive metabolites that covalently modify CYP3A4 Cys239 and cause time-dependent inhibition of the enzyme., 40 (7): [PMID:22517972] [10.1124/dmd.112.045708] |
442. Jin Y, Zollinger M, Borell H, Zimmerlin A, Patten CJ.. (2011) CYP4F enzymes are responsible for the elimination of fingolimod (FTY720), a novel treatment of relapsing multiple sclerosis., 39 (2): [PMID:21045201] [10.1124/dmd.110.035378] |
443. Lundahl A, Hedeland M, Bondesson U, Lennernäs H.. (2011) In vivo investigation in pigs of intestinal absorption, hepatobiliary disposition, and metabolism of the 5α-reductase inhibitor finasteride and the effects of coadministered ketoconazole., 39 (5): [PMID:21317368] [10.1124/dmd.110.035311] |
444. Kamiński K, Zagaja M, Łuszczki JJ, Rapacz A, Andres-Mach M, Latacz G, Kieć-Kononowicz K.. (2015) Design, synthesis, and anticonvulsant activity of new hybrid compounds derived from 2-(2,5-dioxopyrrolidin-1-yl)propanamides and 2-(2,5-dioxopyrrolidin-1-yl)butanamides., 58 (13): [PMID:26052884] [10.1021/acs.jmedchem.5b00578] |
445. Liaras K, Geronikaki A, Glamoclija J, Ciric A, Sokovic M. (2014) Thiazole-based aminopyrimidines and N-phenylpyrazolines as potent antimicrobial agents: synthesis and biological evaluation, 5 (7): [10.1039/C4MD00124A] |
446. Shahavar Sulthana S, Arul Antony S, Balachandran C, Syed Shafi S.. (2015) Thiophene and benzodioxole appended thiazolyl-pyrazoline compounds: Microwave assisted synthesis, antimicrobial and molecular docking studies., 25 (14): [PMID:26028159] [10.1016/j.bmcl.2015.05.033] |
447. Pingaew R, Prachayasittikul V, Mandi P, Nantasenamat C, Prachayasittikul S, Ruchirawat S, Prachayasittikul V.. (2015) Synthesis and molecular docking of 1,2,3-triazole-based sulfonamides as aromatase inhibitors., 23 (13): [PMID:25934226] [10.1016/j.bmc.2015.04.036] |
448. Joshi P, Singh S, Wani A, Sharma S, Jain SK, Singh B, Gupta BD, Satti NK, Koul S, Khan IA, Kumar A, Bharate SB, Vishwakarma RA. (2014) Osthol and curcumin as inhibitors of human Pgp and multidrug efflux pumps of Staphylococcus aureus: reversing the resistance against frontline antibacterial drugs, 5 (10): [10.1039/C4MD00196F] |
449. Nguyen ST, Kwasny SM, Ding X, Williams JD, Peet NP, Bowlin TL, Opperman TJ.. (2015) Synthesis and antifungal evaluation of head-to-head and head-to-tail bisamidine compounds., 23 (17): [PMID:26209266] [10.1016/j.bmc.2015.07.006] |
450. Zahanich I, Kondratov I, Naumchyk V, Kheylik Y, Platonov M, Zozulya S, Krasavin M.. (2015) Phenoxymethyl 1,3-oxazoles and 1,2,4-oxadiazoles as potent and selective agonists of free fatty acid receptor 1 (GPR40)., 25 (16): [PMID:26096679] [10.1016/j.bmcl.2015.06.018] |
451. Roman BI, De Ryck T, Patronov A, Slavov SH, Vanhoecke BW, Katritzky AR, Bracke ME, Stevens CV.. (2015) 4-Fluoro-3',4',5'-trimethoxychalcone as a new anti-invasive agent. From discovery to initial validation in an in vivo metastasis model., 101 [PMID:26204510] [10.1016/j.ejmech.2015.06.029] |
452. Chennakesava Rao K, Easwaramoorthi K, Arun Y, Balachandran C, Muralidhara Rao KS, Govindhan M, Emi N, Prakasam T, Perumal PT.. (2015) Synthesis of BF₃ catalyzed Mannich derivatives with excellent ee from phenylpropanolamine, study of their antimicrobial activity and molecular docking., 25 (19): [PMID:26296475] [10.1016/j.bmcl.2015.07.096] |
453. Kamińska K, Ziemba J, Ner J, Schwed JS, Łażewska D, Więcek M, Karcz T, Olejarz A, Latacz G, Kuder K, Kottke T, Zygmunt M, Sapa J, Karolak-Wojciechowska J, Stark H, Kieć-Kononowicz K.. (2015) (2-Arylethenyl)-1,3,5-triazin-2-amines as a novel histamine H4 receptor ligands., 103 [PMID:26360048] [10.1016/j.ejmech.2015.08.014] |
454. Elkamhawy A, Viswanath AN, Pae AN, Kim HY, Heo JC, Park WK, Lee CO, Yang H, Kim KH, Nam DH, Seol HJ, Cho H, Roh EJ.. (2015) Discovery of potent and selective cytotoxic activity of new quinazoline-ureas against TMZ-resistant glioblastoma multiforme (GBM)., 103 [PMID:26355532] [10.1016/j.ejmech.2015.08.001] |
455. IC50 data for the L-type calcium channel extracted from a set of literature articles, |
456. (2015) Metalloenzyme inhibitor compounds, |
457. Pitta E, Tsolaki E, Geronikaki A, Petrovic J, Glamoclija J, Sokovic M, Crespan E, Maga G, Bhunia SS, Saxena AK. (2015) 4-Thiazolidinone derivatives as potent antimicrobial agents: microwave-assisted synthesis, biological evaluation and docking studies, 6 (2): [10.1039/C4MD00399C] |
458. Silva-Ortiz AV, Bratoeff E, Ramírez-Apan T, Heuze Y, Sánchez A, Soriano J, Cabeza M.. (2015) Synthesis and activity of novel 16-dehydropregnenolone acetate derivatives as inhibitors of type 1 5α-reductase and on cancer cell line SK-LU-1., 23 (24): [PMID:26631442] [10.1016/j.bmc.2015.10.047] |
459. De Monte C, Carradori S, Bizzarri B, Bolasco A, Caprara F, Mollica A, Rivanera D, Mari E, Zicari A, Akdemir A, Secci D.. (2016) Anti-Candida activity and cytotoxicity of a large library of new N-substituted-1,3-thiazolidin-4-one derivatives., 107 [PMID:26562544] [10.1016/j.ejmech.2015.10.048] |
460. Pawar K, Yadav A, Prasher P, Mishra S, Singh B, Singh P, Komath SS. (2015) Identification of an indoletriazoleamino acid conjugate as a highly effective antifungal agent, 6 (7): [10.1039/C5MD00156K] |
461. Kuder K, Łażewska D, Latacz G, Schwed JS, Karcz T, Stark H, Karolak-Wojciechowska J, Kieć-Kononowicz K.. (2016) Chlorophenoxy aminoalkyl derivatives as histamine H(3)R ligands and antiseizure agents., 24 (2): [PMID:26690914] [10.1016/j.bmc.2015.11.021] |
462. Altıntop MD, Atlı Ö, Ilgın S, Demirel R, Özdemir A, Kaplancıklı ZA.. (2016) Synthesis and biological evaluation of new naphthalene substituted thiosemicarbazone derivatives as potent antifungal and anticancer agents., 108 [PMID:26706351] [10.1016/j.ejmech.2015.11.041] |
463. Kucwaj-Brysz K, Warszycki D, Podlewska S, Witek J, Witek K, González Izquierdo A, Satała G, Loza MI, Lubelska A, Latacz G, Bojarski AJ, Castro M, Kieć-Kononowicz K, Handzlik J.. (2016) Rational design in search for 5-phenylhydantoin selective 5-HT7R antagonists. Molecular modeling, synthesis and biological evaluation., 112 [PMID:26900658] [10.1016/j.ejmech.2016.02.024] |
464. Good JA, Silver J, Núñez-Otero C, Bahnan W, Krishnan KS, Salin O, Engström P, Svensson R, Artursson P, Gylfe Å, Bergström S, Almqvist F.. (2016) Thiazolino 2-Pyridone Amide Inhibitors of Chlamydia trachomatis Infectivity., 59 (5): [PMID:26849778] [10.1021/acs.jmedchem.5b01759] |
465. Krasavin M, Lukin A, Zhurilo N, Kovalenko A, Zahanich I, Zozulya S, Moore D, Tikhonova IG.. (2016) Novel free fatty acid receptor 1 (GPR40) agonists based on 1,3,4-thiadiazole-2-carboxamide scaffold., 24 (13): [PMID:27229618] [10.1016/j.bmc.2016.04.065] |
466. Billamboz M, Suchaud V, Bailly F, Lion C, Andréola ML, Christ F, Debyser Z, Cotelle P.. (2016) 2-hydroxyisoquinoline-1,3(2H,4H)-diones (HIDs) as human immunodeficiency virus type 1 integrase inhibitors: Influence of the alkylcarboxamide substitution of position 4., 117 [PMID:27105029] [10.1016/j.ejmech.2016.03.083] |
467. Secci D, Carradori S, Bizzarri B, Chimenti P, De Monte C, Mollica A, Rivanera D, Zicari A, Mari E, Zengin G, Aktumsek A.. (2016) Novel 1,3-thiazolidin-4-one derivatives as promising anti-Candida agents endowed with anti-oxidant and chelating properties., 117 [PMID:27100030] [10.1016/j.ejmech.2016.04.012] |
468. Wang Y, Chen F, Di H, Xu Y, Xiao Q, Wang X, Wei H, Lu Y, Zhang L, Zhu J, Sheng C, Lan L, Li J.. (2016) Discovery of Potent Benzofuran-Derived Diapophytoene Desaturase (CrtN) Inhibitors with Enhanced Oral Bioavailability for the Treatment of Methicillin-Resistant Staphylococcus aureus (MRSA) Infections., 59 (7): [PMID:26999509] [10.1021/acs.jmedchem.5b01984] |
469. Wang HY, Qin Y, Li H, Roman LJ, Martásek P, Poulos TL, Silverman RB.. (2016) Potent and Selective Human Neuronal Nitric Oxide Synthase Inhibition by Optimization of the 2-Aminopyridine-Based Scaffold with a Pyridine Linker., 59 (10): [PMID:27050842] [10.1021/acs.jmedchem.6b00273] |
470. Carosati E, Cosimelli B, Ioan P, Severi E, Katneni K, Chiu FC, Saponara S, Fusi F, Frosini M, Matucci R, Micucci M, Chiarini A, Spinelli D, Budriesi R.. (2016) Understanding Oxadiazolothiazinone Biological Properties: Negative Inotropic Activity versus Cytochrome P450-Mediated Metabolism., 59 (7): [PMID:26962886] [10.1021/acs.jmedchem.6b00030] |
471. Smutny T, Nova A, Drechslerová M, Carazo A, Hyrsova L, Hrušková ZR, Kuneš J, Pour M, Špulák M, Pavek P.. (2016) 2-(3-Methoxyphenyl)quinazoline Derivatives: A New Class of Direct Constitutive Androstane Receptor (CAR) Agonists., 59 (10): [PMID:27145071] [10.1021/acs.jmedchem.5b01891] |
472. Wang Y, Di H, Chen F, Xu Y, Xiao Q, Wang X, Wei H, Lu Y, Zhang L, Zhu J, Lan L, Li J.. (2016) Discovery of Benzocycloalkane Derivatives Efficiently Blocking Bacterial Virulence for the Treatment of Methicillin-Resistant S. aureus (MRSA) Infections by Targeting Diapophytoene Desaturase (CrtN)., 59 (10): [PMID:27139780] [10.1021/acs.jmedchem.6b00122] |
473. WHO Anatomical Therapeutic Chemical Classification, |
474. British National Formulary (72nd edition), |
475. Kovács D, Wölfling J, Szabó N, Szécsi M, Schelz Z, Zupkó I, Frank É.. (2016) Synthesis of novel 17-(4'-formyl)pyrazolylandrosta-5,16-dienes and their derivatives as potent 17α-hydroxylase/C17,20-lyase inhibitors or antiproliferative agents depending on the substitution pattern of the heteroring., 120 [PMID:27209562] [10.1016/j.ejmech.2016.05.006] |
476. Swanson DM, Savall BM, Coe KJ, Schoetens F, Koudriakova T, Skaptason J, Wall J, Rech J, Deng X, De Angelis M, Everson A, Lord B, Wang Q, Ao H, Scott B, Sepassi K, Lovenberg TW, Carruthers NI, Bhattacharya A, Letavic MA.. (2016) Identification of (R)-(2-Chloro-3-(trifluoromethyl)phenyl)(1-(5-fluoropyridin-2-yl)-4-methyl-6,7-dihydro-1H-imidazo[4,5-c]pyridin-5(4H)-yl)methanone (JNJ 54166060), a Small Molecule Antagonist of the P2X7 receptor., 59 (18): [PMID:27548392] [10.1021/acs.jmedchem.6b00989] |
477. Rackelmann N, Matter H, Englert H, Follmann M, Maier T, Weston J, Arndt P, Heyse W, Mertsch K, Wirth K, Bialy L.. (2016) Discovery and Optimization of 1-Phenoxy-2-aminoindanes as Potent, Selective, and Orally Bioavailable Inhibitors of the Na+/H+ Exchanger Type 3 (NHE3)., 59 (19): [PMID:27606885] [10.1021/acs.jmedchem.6b00624] |
478. Guda R, Narsimha S, Babu R, Muthadi S, Lingabathula H, Palabindela R, Yellu NR, Kumar G, Kasula M.. (2016) Novel substituted hydrazono indolo[2,1-b]quinazoline-6,12-dione analogues as cytostatic agents: Synthesis, crystal structure, biological evaluation and molecular docking studies., 26 (22): [PMID:27769618] [10.1016/j.bmcl.2016.10.006] |
479. Sravya G, Yamini G, Padmavathi V, Padmaja A.. (2016) Synthesis and antimicrobial activity of styryl/pyrrolyl/pyrazolyl sulfonylmethyl-1,3,4-oxadiazolyl amines and styryl/pyrrolyl/pyrazolyl sulfonylmethyl-1,3,4-thiadiazolyl amines., 122 [PMID:27448921] [10.1016/j.ejmech.2016.06.014] |
480. Blass BE, Iyer P, Abou-Gharbia M, Childers WE, Gordon JC, Ramanjulu M, Morton G, Arumugam P, Boruwa J, Ellingboe J, Mitra S, Nimmareddy RR, Paliwal S, Rajasekhar J, Shivakumar S, Srivastava P, Tangirala RS, Venkataramanaiah K, Yanamandra M.. (2016) Design, synthesis, and evaluation of (2S,4R)-Ketoconazole sulfonamide analogs as potential treatments for Metabolic Syndrome., 26 (23): [PMID:27789139] [10.1016/j.bmcl.2016.10.016] |
481. Blass BE, Iyer P, Abou-Gharbia M, Childers WE, Gordon JC, Ramanjulu M, Morton G, Arumugam P, Boruwa J, Ellingboe J, Mitra S, Nimmareddy RR, Paliwal S, Rajasekhar J, Shivakumar S, Srivastava P, Tangirala RS, Venkataramanaiah K, Yanamandra M.. (2016) Design, synthesis, and evaluation of (2S,4R)-Ketoconazole sulfonamide analogs as potential treatments for Metabolic Syndrome., 26 (23): [PMID:27789139] [10.1016/j.bmcl.2016.10.016] |
482. Reddy GM, Garcia JR, Reddy VH, de Andrade AM, Camilo A, Pontes Ribeiro RA, de Lazaro SR.. (2016) Synthesis, antimicrobial activity and advances in structure-activity relationships (SARs) of novel tri-substituted thiazole derivatives., 123 [PMID:27494167] [10.1016/j.ejmech.2016.07.062] |
483. Zhao D, Zhao S, Zhao L, Zhang X, Wei P, Liu C, Hao C, Sun B, Su X, Cheng M.. (2017) Discovery of biphenyl imidazole derivatives as potent antifungal agents: Design, synthesis, and structure-activity relationship studies., 25 (2): [PMID:27955926] [10.1016/j.bmc.2016.11.051] |
484. Open TG-GATES, [10.6019/CHEMBL3885861] |
485. DrugMatrix, [10.6019/CHEMBL3885881] |
486. (2015) Metalloenzyme inhibitor compounds, |
487. (2015) Phospholipid drug analogs, |
488. (2015) Cosmetic compositions containing substituted azole and methods for improving the appearance of aging skin, |
489. (2015) Cosmetic compositions containing substituted azole and methods for alleviating the signs of photoaged skin, |
490. (2015) Phospholipid drug analogs, |
491. (2016) Selective inhibitors of human corticosteroid synthases, |
492. (2016) Selective CYP11B1 inhibitors for the treatment of cortisol dependent diseases, |
493. Tzvetkov NT, Stammler HG, Neumann B, Hristova S, Antonov L, Gastreich M.. (2017) Crystal structures, binding interactions, and ADME evaluation of brain penetrant N-substituted indazole-5-carboxamides as subnanomolar, selective monoamine oxidase B and dual MAO-A/B inhibitors., 127 [PMID:28107736] [10.1016/j.ejmech.2017.01.011] |
494. Zhang W, Liu J, Macho JM, Jiang X, Xie D, Jiang F, Liu W, Fu L.. (2017) Design, synthesis and antimicrobial evaluation of novel benzoxazole derivatives., 126 [PMID:27744188] [10.1016/j.ejmech.2016.10.010] |
495. Metcalf B, Chuang C, Dufu K, Patel MP, Silva-Garcia A, Johnson C, Lu Q, Partridge JR, Patskovska L, Patskovsky Y, Almo SC, Jacobson MP, Hua L, Xu Q, Gwaltney SL, Yee C, Harris J, Morgan BP, James J, Xu D, Hutchaleelaha A, Paulvannan K, Oksenberg D, Li Z.. (2017) Discovery of GBT440, an Orally Bioavailable R-State Stabilizer of Sickle Cell Hemoglobin., 8 (3): [PMID:28337324] [10.1021/acsmedchemlett.6b00491] |
496. Chen EC, Khuri N, Liang X, Stecula A, Chien HC, Yee SW, Huang Y, Sali A, Giacomini KM.. (2017) Discovery of Competitive and Noncompetitive Ligands of the Organic Cation Transporter 1 (OCT1; SLC22A1)., 60 (7): [PMID:28230985] [10.1021/acs.jmedchem.6b01317] |
497. Morgan RE, Trauner M, van Staden CJ, Lee PH, Ramachandran B, Eschenberg M, Afshari CA, Qualls CW, Lightfoot-Dunn R, Hamadeh HK.. (2010) Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development., 118 (2): [PMID:20829430] [10.1093/toxsci/kfq269] |
498. Aleo MD, Luo Y, Swiss R, Bonin PD, Potter DM, Will Y.. (2014) Human drug-induced liver injury severity is highly associated with dual inhibition of liver mitochondrial function and bile salt export pump., 60 (3): [PMID:24799086] [10.1002/hep.27206] |
499. Warner DJ, Chen H, Cantin LD, Kenna JG, Stahl S, Walker CL, Noeske T.. (2012) Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification., 40 (12): [PMID:22961681] [10.1124/dmd.112.047068] |
500. McEneny-King A, Osman W, Edginton AN, Rao PPN.. (2017) Cytochrome P450 binding studies of novel tacrine derivatives: Predicting the risk of hepatotoxicity., 27 (11): [PMID:28400237] [10.1016/j.bmcl.2017.04.006] |
501. Ni S, Wei H, Li B, Chen F, Liu Y, Chen W, Xu Y, Qiu X, Li X, Lu Y, Liu W, Hu L, Lin D, Wang M, Zheng X, Mao F, Zhu J, Lan L, Li J.. (2017) Novel Inhibitors of Staphyloxanthin Virulence Factor in Comparison with Linezolid and Vancomycin versus Methicillin-Resistant, Linezolid-Resistant, and Vancomycin-Intermediate Staphylococcus aureus Infections in Vivo., 60 (19): [PMID:28880552] [10.1021/acs.jmedchem.7b00949] |
502. Zha GF, Leng J, Darshini N, Shubhavathi T, Vivek HK, Asiri AM, Marwani HM, Rakesh KP, Mallesha N, Qin HL.. (2017) Synthesis, SAR and molecular docking studies of benzo[d]thiazole-hydrazones as potential antibacterial and antifungal agents., 27 (14): [PMID:28539243] [10.1016/j.bmcl.2017.05.032] |
503. Li B, Ni S, Mao F, Chen F, Liu Y, Wei H, Chen W, Zhu J, Lan L, Li J.. (2018) Novel Terminal Bipheny-Based Diapophytoene Desaturases (CrtN) Inhibitors as Anti-MRSA/VISR/LRSA Agents with Reduced hERG Activity., 61 (1): [PMID:29243920] [10.1021/acs.jmedchem.7b01300] |
504. Patel BA, Abel B, Barbuti AM, Velagapudi UK, Chen ZS, Ambudkar SV, Talele TT.. (2018) Comprehensive Synthesis of Amino Acid-Derived Thiazole Peptidomimetic Analogues to Understand the Enigmatic Drug/Substrate-Binding Site of P-Glycoprotein., 61 (3): [PMID:29251928] [10.1021/acs.jmedchem.7b01340] |
505. Morgan RE, van Staden CJ, Chen Y, Kalyanaraman N, Kalanzi J, Dunn RT, Afshari CA, Hamadeh HK.. (2013) A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development., 136 (1): [PMID:23956101] [10.1093/toxsci/kft176] |
506. Chen M, Suzuki A, Thakkar S, Yu K, Hu C, Tong W.. (2016) DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans., 21 (4): [PMID:26948801] [10.1016/j.drudis.2016.02.015] |
507. Xie F, Ni T, Zhao J, Pang L, Li R, Cai Z, Ding Z, Wang T, Yu S, Jin Y, Zhang D, Jiang Y.. (2017) Design, synthesis, and in vitro evaluation of novel antifungal triazoles., 27 (10): [PMID:28372907] [10.1016/j.bmcl.2017.03.062] |
508. Taban IM, Zhu J, DeLuca HF, Simons C.. (2017) Analysis of the binding sites of vitamin D 1α-hydroxylase (CYP27B1) and vitamin D 24-hydroxylase (CYP24A1) for the design of selective CYP24A1 inhibitors: Homology modelling, molecular dynamics simulations and identification of key binding requirements., 25 (20): [PMID:28886997] [10.1016/j.bmc.2017.08.036] |
509. Qiu Q, Shi W, Li Z, Zhang B, Pan M, Cui J, Dai Y, Huang W, Qian H.. (2017) Exploration of 2-((Pyridin-4-ylmethyl)amino)nicotinamide Derivatives as Potent Reversal Agents against P-Glycoprotein-Mediated Multidrug Resistance., 60 (7): [PMID:28301155] [10.1021/acs.jmedchem.6b01879] |
510. Qiu Q, Liu B, Cui J, Li Z, Deng X, Qiang H, Li J, Liao C, Zhang B, Shi W, Pan M, Huang W, Qian H.. (2017) Design, Synthesis, and Pharmacological Characterization of N-(4-(2 (6,7-Dimethoxy-3,4-dihydroisoquinolin-2(1H)yl)ethyl)phenyl)quinazolin-4-amine Derivatives: Novel Inhibitors Reversing P-Glycoprotein-Mediated Multidrug Resistance., 60 (8): [PMID:28355069] [10.1021/acs.jmedchem.6b01787] |
511. Taban IM, Zhu J, DeLuca HF, Simons C.. (2017) Synthesis, molecular modelling and CYP24A1 inhibitory activity of novel of (E)-N-(2-(1H-imidazol-1-yl)-2-(phenylethyl)-3/4-styrylbenzamides., 25 (15): [PMID:28601511] [10.1016/j.bmc.2017.05.055] |
512. Zhao S, Zhang X, Wei P, Su X, Zhao L, Wu M, Hao C, Liu C, Zhao D, Cheng M.. (2017) Design, synthesis and evaluation of aromatic heterocyclic derivatives as potent antifungal agents., 137 [PMID:28558334] [10.1016/j.ejmech.2017.05.043] |
513. Łażewska D, Kaleta M, Hagenow S, Mogilski S, Latacz G, Karcz T, Lubelska A, Honkisz E, Handzlik J, Reiner D, Satała G, Filipek B, Stark H, Kieć-Kononowicz K.. (2018) Novel naphthyloxy derivatives - Potent histamine H3 receptor ligands. Synthesis and pharmacological evaluation., 26 (9): [PMID:29681486] [10.1016/j.bmc.2018.04.023] |
514. O' Neill PM, Stocks PA, Sabbani S, Roberts NL, Amewu RK, Shore ER, Aljayyoussi G, Angulo-Barturén I, Belén M, Jiménez-Díaz, Bazaga SF, Martínez MS, Campo B, Sharma R, Charman SA, Ryan E, Chen G, Shackleford DM, Davies J, Nixon GL, Biagini GA, Ward SA.. (2018) Synthesis and profiling of benzylmorpholine 1,2,4,5-tetraoxane analogue N205: Towards tetraoxane scaffolds with potential for single dose cure of malaria., 26 (11): [PMID:29779669] [10.1016/j.bmc.2018.05.006] |
515. Unpublished dataset, |
516. Bernhard Ellinger, Denisa Bojkova, Andrea Zaliani, Jindrich Cinatl, Carsten Claussen, Sandra Westhaus, Jeanette Reinshagen, Maria Kuzikov, Markus Wolf, Gerd Geisslinger, Philip Gribbon, Sandra Ciesek. (2020) Identification of inhibitors of SARS-CoV-2 in-vitro cellular toxicity in human (Caco-2) cells using a large scale drug repurposing collection, [10.21203/rs.3.rs-23951/v1] |
517. Elias R, Benhamou RI, Jaber QZ, Dorot O, Zada SL, Oved K, Pichinuk E, Fridman M.. (2019) Antifungal activity, mode of action variability, and subcellular distribution of coumarin-based antifungal azoles., 179 [PMID:31288127] [10.1016/j.ejmech.2019.07.003] |
518. Maria Kuzikov, Elisa Costanzi, Jeanette Reinshagen, Francesca Esposito, Laura Vangeel, Markus Wolf, Bernhard Ellinger, Carsten Claussen, Gerd Geisslinger, Angela Corona, Daniela Iaconis, Carmine Talarico, Candida Manelfi, Rolando Cannalire, Giulia Rossetti, Jonas Gossen, Simone Albani, Francesco Musiani, Katja Herzog, Yang Ye, Barbara Giabbai, Nicola Demitri, Dirk Jochmans, Steven De Jonghe, Jasper Rymenants, Vincenzo Summa, Enzo Tramontano, Andrea R. Beccari, Pieter Leyssen, Paola Storici, Johan Neyts, Philip Gribbon, and Andrea Zaliani. (2020) Identification of inhibitors of SARS-Cov2 M-Pro enzymatic activity using a small molecule repurposing screen, [10.6019/CHEMBL4495564] |
519. Andrea Zaliani, Laura Vangeel, Jeanette Reinshagen, Daniela Iaconis, Maria Kuzikov, Oliver Keminer, Markus Wolf, Bernhard Ellinger, Francesca Esposito, Angela Corona, Enzo Tramontano, Candida Manelfi, Katja Herzog, Dirk Jochmans, Steven De Jonghe, Winston Chiu, Thibault Francken, Joost Schepers, Caroline Collard, Kayvan Abbasi, Carsten Claussen , Vincenzo Summa, Andrea R. Beccari, Johan Neyts, Philip Gribbon and Pieter Leyssen. (2020) Cytopathic SARS-Cov2 screening on VERO-E6 cells in a large repurposing effort, [10.6019/CHEMBL4495565] |
520. Johannes Zuegg, Alysha Elliott, Maite Amado, Emma Cowie, Ali Hinton, Geraldine Kaeslin, Angela Kavanagh, Anne Kunert, Gabriell Lowe, Soumya Ramu, Janet Reid, Robin Trauer, Mathilde Desselle, Ruth Neale, Karl Hansford, Mark Blascovich, Matthew Cooper. CO-ADD screening of MMV (CH) - Pandemic Response Box, [10.6019/CHEMBL4513161] |
521. Unpublished dataset, |
522. Tóth B, Hohmann J, Vasas A.. (2018) Phenanthrenes: A Promising Group of Plant Secondary Metabolites., 81 (3.0): [PMID:29280630] [10.1021/acs.jnatprod.7b00619] |
523. Holbrook SYL, Garzan A, Dennis EK, Shrestha SK, Garneau-Tsodikova S.. (2017) Repurposing antipsychotic drugs into antifungal agents: Synergistic combinations of azoles and bromperidol derivatives in the treatment of various fungal infections., 139 [PMID:28797882] [10.1016/j.ejmech.2017.07.030] |
524. Troncoso ME, Germanó MJ, Arrieta VJ, García Bustos MF, Cifuente D, Cargnelutti DE, Lozano ES.. (2023) Antiparasitic Activity of Two Natural Terpenes from Salvia cuspidata against Leishmania amazonensis., 86 (4): [PMID:36857574] [10.1021/acs.jnatprod.2c00976] |
525. Asakawa Y, Ludwiczuk A.. (2018) Chemical Constituents of Bryophytes: Structures and Biological Activity., 81 (3): [PMID:29019405] [10.1021/acs.jnatprod.6b01046] |
526. Sutherland JJ, Yonchev D, Fekete A, Urban L.. (2023) A preclinical secondary pharmacology resource illuminates target-adverse drug reaction associations of marketed drugs., 14 (1): [PMID:37468498] [10.1038/s41467-023-40064-9] |
527. European Medicines Agency, |